| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | | | | | | | | | | | | | | | | | | | |
|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.3 | | | | | 0 - 5 | mg/L |
| 4 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Total Bilirubin | | 8 | | | | | 3 - 21 | umol/L |
| 5 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.2 | | | | | 0 - 6.2 | umol/L |
| 6 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Alkaline Phosphatase | | 71 | | | | | 35 - 104 | U/L |
| 7 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | ALT (SGPT) | | 26 | | | | | 4 - 43 | U/L |
| 8 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | AST (SGOT) | | 36 | | | | | 8 - 40 | U/L |
| 9 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | GGT | | 55 | | H | | | 4 - 49 | U/L |
| 10 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | LDH | | 218 | | | | | 53 - 234 | U/L |
| 11 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Urea Nitrogen | | 7.1 | | | | | 1.4 - 8.6 | mmol/L |
| 12 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 68 | | | | | 31 - 101 | umol/L |
| 13 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 14 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Serum Uric Acid | | 359 | | | | | 149 - 446 | umol/L |
| 15 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 16 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Phosphorus | | 1.09 | | | | | 0.71 - 1.65 | mmol/L |
| 17 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Total Protein | | 71 | | | | | 61 - 84 | g/L |
| 18 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 19 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Creatine Kinase | | 187 | | | | | 26 - 192 | U/L |
| 20 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 21 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 22 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.8 | | | | | 19.3 - 29.3 | mmol/L |
| 23 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | CHEMISTRY PANEL | Serum Chloride | | 100 | | | | | 94 - 112 | mmol/L |
| 24 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 137 | | | | | 116 - 164 | g/L |
| 25 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.41 | | | | | 0.34 - 0.48 | |
| 26 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.4 | | | | | 4.1 - 5.6 | TI/L |
| 27 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 28 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 95 | | | | | 79 - 98 | fL |
| 29 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.76 | | | | | 3.8 - 10.7 | GI/L |
| 30 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.50 | | | | | 1.96 - 7.23 | GI/L |
| 31 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.54 | | | | | 0.91 - 4.28 | GI/L |
| 32 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.63 | | | | | 0.12 - 0.92 | GI/L |
| 33 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.07 | | | | | 0 - 0.57 | GI/L |
| 34 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.03 | | | | | 0 - 0.2 | GI/L |
| 35 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 60.7 | | | | | 40.5 - 75 | % |
| 36 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 26.8 | | | | | 15.4 - 48.5 | % |
| 37 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 10.9 | R | H | | | 2.6 - 10.1 | % |
| 38 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.1 | | | | | 0 - 6.8 | % |
| 39 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 40 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 275 | | | | | 140 - 400 | GI/L |
| 41 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | | | | | | | |
| 42 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | | | | | | | |
| 43 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | LIPID PANEL | Direct HDL-C 4th Generation | | 2.58 | | H | | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L |
| 44 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | LIPID PANEL | Triglycerides (GPO) | | 1.71 | | | | | 0.59 - 2.96 | mmol/L |
| 45 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | LIPID PANEL | Cholesterol (High Performance) | | 4.84 | | | | | 4.42 - 7.53 | mmol/L |
| 46 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.48 | | | | | 0 - 3.34 | mmol/L |
| 47 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | RETICULOCYTES | Reticulocyte Count % | | 1.6 | | | | | 0.6 - 2.5 | % |
| 48 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Specific Gravity | | 1.013 | | | | | 1 - 1.04 | |
| 49 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur pH | | 5.0 | | | | | 5 - 8 | |
| 50 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 51 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 52 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 53 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 54 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 55 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 56 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 57 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 11:15 AM | 6226573502 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 58 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.6 | | | | | 0 - 5 | mg/L |
| 59 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Total Bilirubin | | 6 | | | | | 3 - 21 | umol/L |
| 60 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.0 | | | | | 0 - 6.2 | umol/L |
| 61 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Alkaline Phosphatase | | 52 | | | | | 35 - 104 | U/L |
| 62 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | ALT (SGPT) | | 17 | | | | | 4 - 43 | U/L |
| 63 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | AST (SGOT) | | 19 | | | | | 8 - 40 | U/L |
| 64 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | GGT | | 18 | | | | | 5 - 50 | U/L |
| 65 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | LDH | | 176 | | | | | 53 - 234 | U/L |
| 66 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Urea Nitrogen | | 4.4 | | | | | 1.4 - 8.6 | mmol/L |
| 67 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 60 | | | | | 31 - 101 | umol/L |
| 68 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Glucose Fasting | | 3.9 | | | | | 3.9 - 5.6 | mmol/L |
| 69 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Serum Uric Acid | | 183 | | | | | 149 - 446 | umol/L |
| 70 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.36 | | | | | 2.07 - 2.64 | mmol/L |
| 71 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Phosphorus | | 0.78 | | | | | 0.71 - 1.65 | mmol/L |
| 72 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Total Protein | | 61 | | | | | 60 - 80 | g/L |
| 73 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Albumin-BCG | | 41 | | | | | 33 - 49 | g/L |
| 74 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Creatine Kinase | | 98 | | | | | 26 - 192 | U/L |
| 75 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 135 - 145 | mmol/L |
| 76 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Serum Potassium | | 3.9 | | | | | 3.5 - 5.2 | mmol/L |
| 77 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Serum Bicarbonate | | 24.4 | | | | | 19.3 - 29.3 | mmol/L |
| 78 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | CHEMISTRY PANEL | Serum Chloride | | 105 | | | | | 94 - 112 | mmol/L |
| 79 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | | | | Test cancelled: Expired contain, test cancel | | | |
| 80 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | | | | Test cancelled: Expired contain, test cancel | | | |
| 81 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | | | | Test cancelled: Expired contain, test cancel | | | |
| 82 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | | | | Test cancelled: Expired contain, test cancel | | | |
| 83 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | | | | Test cancelled: Expired contain, test cancel | | | |
| 84 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | | | | Test cancelled: Expired contain, test cancel | | | |
| 85 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | | | | Test cancelled: Expired contain, test cancel | | | |
| 86 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | | | | Test cancelled: Expired contain, test cancel | | | |
| 87 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | | | | Test cancelled: Expired contain, test cancel | | | |
| 88 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | | | | Test cancelled: Expired contain, test cancel | | | |
| 89 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | | | | Test cancelled: Expired contain, test cancel | | | |
| 90 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | | | | Test cancelled: Expired contain, test cancel | | | |
| 91 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | | | | Test cancelled: Expired contain, test cancel | | | |
| 92 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | | | | Test cancelled: Expired contain, test cancel | | | |
| 93 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | | | | Test cancelled: Expired contain, test cancel | | | |
| 94 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | | | | Test cancelled: Expired contain, test cancel | | | |
| 95 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | | | | Test cancelled: Expired contain, test cancel | | | |
| 96 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | | | | | | | |
| 97 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | | | | | | | |
| 98 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.35 | | | | | 1.03 - 1.53 | mmol/L |
| 99 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | LIPID PANEL | Triglycerides (GPO) | | 0.82 | | | | | 0.63 - 2.71 | mmol/L |
| 100 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | LIPID PANEL | Cholesterol (High Performance) | | 5.15 | | | | | 4.86 - 8.28 | mmol/L |
| 101 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.42 | | H | | | 0 - 3.34 | mmol/L |
| 102 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | RETICULOCYTES | Reticulocyte Count % | | | | | Test cancelled: Expired contain, test cancel | | | |
| 103 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Specific Gravity | | 1.019 | | | | | 1.01 - 1.03 | |
| 104 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 105 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 106 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 107 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 108 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 109 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 110 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 111 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 112 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Day 29 | | Jun 5, 2026 10:35 AM | 6226889397 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 113 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 4.2 | | | | | 0 - 5 | mg/L |
| 114 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Total Bilirubin | | 6 | | | | | 3 - 21 | umol/L |
| 115 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.6 | | | | | 0 - 6.2 | umol/L |
| 116 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Alkaline Phosphatase | | 80 | | | | | 35 - 104 | U/L |
| 117 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | ALT (SGPT) | | 28 | | | | | 4 - 43 | U/L |
| 118 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | AST (SGOT) | | 25 | | | | | 8 - 40 | U/L |
| 119 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | GGT | | 43 | | | | | 4 - 49 | U/L |
| 120 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | LDH | | 177 | | | | | 53 - 234 | U/L |
| 121 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Urea Nitrogen | | 2.4 | | | | | 1.4 - 8.6 | mmol/L |
| 122 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 67 | | | | | 31 - 101 | umol/L |
| 123 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Glucose Fasting | | 5.3 | | | | | 3.9 - 5.6 | mmol/L |
| 124 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Serum Uric Acid | | 277 | | | | | 125 - 428 | umol/L |
| 125 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.40 | | | | | 2.07 - 2.64 | mmol/L |
| 126 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Phosphorus | | 1.12 | | | | | 0.71 - 1.65 | mmol/L |
| 127 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Total Protein | | 72 | | | | | 61 - 84 | g/L |
| 128 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 49 | g/L |
| 129 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Creatine Kinase | | 125 | | | | | 26 - 192 | U/L |
| 130 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Serum Sodium | | 137 | | | | | 132 - 147 | mmol/L |
| 131 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Serum Potassium | | 4.5 | | | | | 3.5 - 5.2 | mmol/L |
| 132 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.5 | | | | | 19.3 - 29.3 | mmol/L |
| 133 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | CHEMISTRY PANEL | Serum Chloride | | 101 | | | | | 94 - 112 | mmol/L |
| 134 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 134 | | | | Result verified by repeat analysis | 116 - 164 | g/L |
| 135 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 136 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.1 | | | | Result verified by repeat analysis | 4.1 - 5.6 | TI/L |
| 137 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 138 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 102 | | H | | | 79 - 98 | fL |
| 139 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 6.65 | | | | Result verified by repeat analysis | 3.8 - 10.7 | GI/L |
| 140 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.18 | | | | Result verified by repeat analysis | 1.96 - 7.23 | GI/L |
| 141 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.87 | | | | | 0.91 - 4.28 | GI/L |
| 142 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.44 | | | | Result verified by repeat analysis | 0.12 - 0.92 | GI/L |
| 143 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.12 | | | | Result verified by repeat analysis | 0 - 0.57 | GI/L |
| 144 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | Result verified by repeat analysis | 0 - 0.2 | GI/L |
| 145 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 47.7 | | | | Result verified by repeat analysis | 40.5 - 75 | % |
| 146 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 43.2 | | | | Result verified by repeat analysis | 15.4 - 48.5 | % |
| 147 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.6 | | | | Result verified by repeat analysis | 2.6 - 10.1 | % |
| 148 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.7 | | | | Result verified by repeat analysis | 0 - 6.8 | % |
| 149 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.8 | | | | Result verified by repeat analysis | 0 - 2 | % |
| 150 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 360 | | | | Result verified by repeat analysis | 140 - 400 | GI/L |
| 151 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.3 | | | | | <6.5 % | |
| 152 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.64 | | | | | 1.9 - 23 | uIU/mL |
| 153 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 154 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.70 | | H | | | 1.03 - 1.53 | mmol/L |
| 155 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | LIPID PANEL | Triglycerides (GPO) | | 1.69 | | | | | 0.51 - 2.42 | mmol/L |
| 156 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | LIPID PANEL | Cholesterol (High Performance) | | 5.66 | | | | | 4.01 - 6.85 | mmol/L |
| 157 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.19 | | | | | 0 - 3.34 | mmol/L |
| 158 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | RETICULOCYTES | Reticulocyte Count % | | 1.3 | | | | | 0.6 - 2.5 | % |
| 159 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | TSH | TSH 3rd IS-QT | | | | | Test group cancelled: No specimen received | | | |
| 160 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Specific Gravity | | 1.015 | | | | | 1 - 1.04 | |
| 161 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 162 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 163 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 164 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 165 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 166 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 167 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 168 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 169 | CZ100040002 | | | 46 | years | Female | Part 2 DB Week 13 | | May 29, 2026 9:30 AM | 6226649754 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 170 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.1 | | | | | 0 - 5 | mg/L |
| 171 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CELLULAR ELEMENTS | Ur WBC/HPF | | 2 | | | | | 0 - 12 | /HPF |
| 172 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 173 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.6 | | | | | 0 - 6.2 | umol/L |
| 174 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Alkaline Phosphatase | | 87 | | | | | 35 - 104 | U/L |
| 175 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | ALT (SGPT) | | 20 | | | | | 4 - 43 | U/L |
| 176 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | AST (SGOT) | | 24 | | | | | 8 - 40 | U/L |
| 177 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | GGT | | 30 | | | | | 4 - 49 | U/L |
| 178 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | LDH | | 154 | | | | | 53 - 234 | U/L |
| 179 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Urea Nitrogen | | 5.2 | | | | | 1.4 - 8.6 | mmol/L |
| 180 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 49 | | | | | 31 - 101 | umol/L |
| 181 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Glucose Fasting | | 4.9 | | | | | 3.9 - 5.6 | mmol/L |
| 182 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Serum Uric Acid | | 314 | | | | | 125 - 428 | umol/L |
| 183 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.51 | | | | | 2.07 - 2.64 | mmol/L |
| 184 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Phosphorus | | 1.25 | | | | | 0.71 - 1.65 | mmol/L |
| 185 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Total Protein | | 74 | | | | | 61 - 84 | g/L |
| 186 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Albumin-BCG | | 47 | | | | | 33 - 49 | g/L |
| 187 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Creatine Kinase | | 202 | | H | | | 26 - 192 | U/L |
| 188 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Serum Sodium | | 138 | | | | | 132 - 147 | mmol/L |
| 189 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Serum Potassium | | 4.8 | | | | | 3.5 - 5.2 | mmol/L |
| 190 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.2 | | | | | 19.3 - 29.3 | mmol/L |
| 191 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | CHEMISTRY PANEL | Serum Chloride | | 103 | | | | | 94 - 112 | mmol/L |
| 192 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 144 | | | | | 116 - 164 | g/L |
| 193 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.44 | | | | | 0.34 - 0.48 | |
| 194 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.5 | | | | | 4.1 - 5.6 | TI/L |
| 195 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 196 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 97 | | | | | 79 - 98 | fL |
| 197 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 8.81 | | | | | 3.8 - 10.7 | GI/L |
| 198 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.47 | | | | | 1.96 - 7.23 | GI/L |
| 199 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.67 | | | | | 0.91 - 4.28 | GI/L |
| 200 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.43 | | | | | 0.12 - 0.92 | GI/L |
| 201 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.17 | | | | | 0 - 0.57 | GI/L |
| 202 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.06 | | | | | 0 - 0.2 | GI/L |
| 203 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 50.7 | | | | | 40.5 - 75 | % |
| 204 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 41.7 | | | | | 15.4 - 48.5 | % |
| 205 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 4.8 | | | | | 2.6 - 10.1 | % |
| 206 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.0 | | | | | 0 - 6.8 | % |
| 207 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.7 | | | | | 0 - 2 | % |
| 208 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 504 | | H | | | 140 - 400 | GI/L |
| 209 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 6.6 | | H | | | <6.5 % | |
| 210 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 23.94 | | H | | | 1.9 - 23 | uIU/mL |
| 211 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 212 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.34 | | | | | 1.03 - 1.53 | mmol/L |
| 213 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | LIPID PANEL | Triglycerides (GPO) | | 2.54 | | H | | | 0.51 - 2.42 | mmol/L |
| 214 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | LIPID PANEL | Cholesterol (High Performance) | | 6.04 | | | | | 4.01 - 6.85 | mmol/L |
| 215 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.54 | | H | | | 0 - 3.34 | mmol/L |
| 216 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | RETICULOCYTES | Reticulocyte Count % | | 1.8 | | | | | 0.6 - 2.5 | % |
| 217 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | TSH | TSH 3rd IS-QT | | 3.138 | | | | | 0.45 - 5.33 | mIU/L |
| 218 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Specific Gravity | | 1.020 | | | | | 1 - 1.04 | |
| 219 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 220 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 221 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 222 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 223 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 224 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 225 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 226 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 227 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Trace | | H | | | Ref Rng:Negative | |
| 228 | CZ100040006 | | | 48 | years | Female | End of Phase/Treatment | | May 22, 2026 12:00 PM | 6228605653 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 229 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 10.2 | | H | | | 0 - 5 | mg/L |
| 230 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Total Bilirubin | | 6 | | | | | 3 - 21 | umol/L |
| 231 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | <1.4 | | | | | 0 - 6.2 | umol/L |
| 232 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Alkaline Phosphatase | | 90 | | | | | 35 - 104 | U/L |
| 233 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | ALT (SGPT) | | 17 | | | | | 4 - 43 | U/L |
| 234 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | AST (SGOT) | | 20 | | | | | 8 - 40 | U/L |
| 235 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | GGT | | 22 | | | | | 5 - 50 | U/L |
| 236 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | LDH | | 185 | | | | | 53 - 234 | U/L |
| 237 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Urea Nitrogen | | 6.0 | | | | | 1.4 - 10.4 | mmol/L |
| 238 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 64 | | | | | 31 - 110 | umol/L |
| 239 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Glucose Fasting | | 6.3 | R | H | | | 3.9 - 5.6 | mmol/L |
| 240 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Serum Uric Acid | | 316 | | | | | 149 - 446 | umol/L |
| 241 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 242 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Phosphorus | | 1.07 | | | | | 0.71 - 1.65 | mmol/L |
| 243 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Total Protein | | 80 | | | | | 60 - 80 | g/L |
| 244 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Albumin-BCG | | 47 | R | H | | | 33 - 46 | g/L |
| 245 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Creatine Kinase | | 88 | | | | | 26 - 192 | U/L |
| 246 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Serum Sodium | | 136 | | | | | 135 - 145 | mmol/L |
| 247 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 248 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Serum Bicarbonate | | 18.7 | R | L | | | 19.3 - 29.3 | mmol/L |
| 249 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | CHEMISTRY PANEL | Serum Chloride | | 101 | | | | | 94 - 112 | mmol/L |
| 250 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 163 | R | H | | | 115 - 158 | g/L |
| 251 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.50 | R | H | | | 0.34 - 0.48 | |
| 252 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.1 | | | | | 3.9 - 5.5 | TI/L |
| 253 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 254 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 97 | | | | | 80 - 100 | fL |
| 255 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 11.22 | R | H | | | 3.8 - 10.7 | GI/L |
| 256 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.82 | | | | | 1.96 - 7.23 | GI/L |
| 257 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.47 | R | H | | | 0.8 - 3 | GI/L |
| 258 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.75 | | | | | 0.12 - 0.92 | GI/L |
| 259 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.11 | | | | | 0 - 0.57 | GI/L |
| 260 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.07 | | | | | 0 - 0.2 | GI/L |
| 261 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 60.8 | | | | | 40.5 - 75 | % |
| 262 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 30.9 | | | | | 15.4 - 48.5 | % |
| 263 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.7 | | | | | 2.6 - 10.1 | % |
| 264 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.0 | | | | | 0 - 6.8 | % |
| 265 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 266 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 285 | | | | | 130 - 394 | GI/L |
| 267 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.9 | | | | | <6.5 % | |
| 268 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 15.61 | | | | | 1.9 - 23 | uIU/mL |
| 269 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 270 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.36 | | | | | 1.03 - 1.53 | mmol/L |
| 271 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | LIPID PANEL | Triglycerides (GPO) | | 2.89 | R | H | | | 0.63 - 2.71 | mmol/L |
| 272 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | LIPID PANEL | Cholesterol (High Performance) | | 7.08 | | | | | 5.35 - 9.1 | mmol/L |
| 273 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.40 | | H | | | 0 - 3.34 | mmol/L |
| 274 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | RETICULOCYTES | Reticulocyte Count % | | 1.1 | | | | | 0.6 - 2.5 | % |
| 275 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | TSH | TSH 3rd IS-QT | | 0.546 | | | | | 0.45 - 5.33 | mIU/L |
| 276 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Specific Gravity | | 1.016 | | | | | 1.01 - 1.03 | |
| 277 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 278 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 279 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 280 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 281 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 282 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 283 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Blood | | Trace | | | | | Ref Rng:$Negative-Trace | |
| 284 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 285 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 286 | CZ100040005 | | | 72 | years | Female | End of Phase/Treatment | | May 22, 2026 9:20 AM | 6228605652 | URINE MICRO PANEL | Ur Microscopic | | Negative | | | | | NEGATIVE$ | NEGATIVE |
| 287 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.3 | | | | | 0 - 5 | mg/L |
| 288 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CELLULAR ELEMENTS | Ur WBC/HPF | | 8 | | | | | 0 - 12 | /HPF |
| 289 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Total Bilirubin | | 8 | | | | | 3 - 21 | umol/L |
| 290 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.2 | | | | | 0 - 6.2 | umol/L |
| 291 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Alkaline Phosphatase | | 83 | | | | | 35 - 104 | U/L |
| 292 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | ALT (SGPT) | | 22 | | | | | 4 - 43 | U/L |
| 293 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | AST (SGOT) | | 24 | | | | | 8 - 40 | U/L |
| 294 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | GGT | | 32 | | | | | 4 - 49 | U/L |
| 295 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | LDH | | 169 | | | | | 53 - 234 | U/L |
| 296 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Urea Nitrogen | | 5.2 | | | | | 1.4 - 8.6 | mmol/L |
| 297 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 51 | | | | | 31 - 101 | umol/L |
| 298 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Glucose Fasting | | 5.0 | | | | | 3.9 - 5.6 | mmol/L |
| 299 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Serum Uric Acid | | 383 | | | | | 125 - 428 | umol/L |
| 300 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.52 | | | | | 2.07 - 2.64 | mmol/L |
| 301 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Phosphorus | | 1.20 | | | | | 0.71 - 1.65 | mmol/L |
| 302 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Total Protein | | 75 | | | | | 61 - 84 | g/L |
| 303 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 304 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Creatine Kinase | | 201 | | H | | | 26 - 192 | U/L |
| 305 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 132 - 147 | mmol/L |
| 306 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Serum Potassium | | 4.8 | | | | | 3.5 - 5.2 | mmol/L |
| 307 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.6 | | | | | 19.3 - 29.3 | mmol/L |
| 308 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 309 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 143 | | | | | 116 - 164 | g/L |
| 310 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 311 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.4 | | | | | 4.1 - 5.6 | TI/L |
| 312 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 313 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 95 | | | | | 79 - 98 | fL |
| 314 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 10.33 | | | | | 3.8 - 10.7 | GI/L |
| 315 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.06 | | | | | 1.96 - 7.23 | GI/L |
| 316 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.53 | | | | | 0.91 - 4.28 | GI/L |
| 317 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.53 | | | | | 0.12 - 0.92 | GI/L |
| 318 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.17 | | | | | 0 - 0.57 | GI/L |
| 319 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | | 0 - 0.2 | GI/L |
| 320 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.6 | | | | | 40.5 - 75 | % |
| 321 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 34.1 | | | | | 15.4 - 48.5 | % |
| 322 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.1 | | | | | 2.6 - 10.1 | % |
| 323 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.6 | | | | | 0 - 6.8 | % |
| 324 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 325 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 525 | R | H | | | 140 - 400 | GI/L |
| 326 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 16.12 | | | | | 1.9 - 23 | uIU/mL |
| 327 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 328 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.37 | | | | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L |
| 329 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | LIPID PANEL | Triglycerides (GPO) | | 2.79 | | H | | | 0.51 - 2.42 | mmol/L |
| 330 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | LIPID PANEL | Cholesterol (High Performance) | | 6.50 | | | | | 4.01 - 6.85 | mmol/L |
| 331 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.85 | | H | | | 0 - 3.34 | mmol/L |
| 332 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | RETICULOCYTES | Reticulocyte Count % | | 1.5 | | | | | 0.6 - 2.5 | % |
| 333 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Specific Gravity | | 1.029 | | | | | 1 - 1.04 | |
| 334 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 335 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Protein | | Trace | | H | | | Ref Rng:Negative | |
| 336 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 337 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 338 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 339 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 340 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 341 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 342 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Trace | | H | | | Ref Rng:Negative | |
| 343 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Day 29 | R | May 5, 2026 1:15 PM | 6227541261 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 344 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.1 | | | | | 0 - 5 | mg/L |
| 345 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Total Bilirubin | | 6 | | | | | 3 - 21 | umol/L |
| 346 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.3 | | | | | 0 - 6.2 | umol/L |
| 347 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Alkaline Phosphatase | | 66 | | | | | 35 - 104 | U/L |
| 348 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | ALT (SGPT) | | 18 | | | | | 4 - 43 | U/L |
| 349 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | AST (SGOT) | | 25 | | | | | 8 - 40 | U/L |
| 350 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | GGT | | 36 | | | | | 4 - 49 | U/L |
| 351 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | LDH | | 192 | | | | | 53 - 234 | U/L |
| 352 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Urea Nitrogen | | 5.2 | | | | | 1.4 - 8.6 | mmol/L |
| 353 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 57 | | | | | 31 - 101 | umol/L |
| 354 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Glucose Fasting | | 4.5 | | | | | 3.9 - 5.6 | mmol/L |
| 355 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Serum Uric Acid | | 277 | | | | | 149 - 446 | umol/L |
| 356 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.08 | | | | | 2.07 - 2.64 | mmol/L |
| 357 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Phosphorus | | 0.90 | | | | | 0.71 - 1.65 | mmol/L |
| 358 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Total Protein | | 62 | | | | | 61 - 84 | g/L |
| 359 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Albumin-BCG | | 41 | | | | | 33 - 49 | g/L |
| 360 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Creatine Kinase | | 84 | | | | | 26 - 192 | U/L |
| 361 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Serum Sodium | | 144 | | | | | 132 - 147 | mmol/L |
| 362 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Serum Potassium | | 3.5 | | | | | 3.5 - 5.2 | mmol/L |
| 363 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Serum Bicarbonate | | 22.5 | | | | | 19.3 - 29.3 | mmol/L |
| 364 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | CHEMISTRY PANEL | Serum Chloride | | 109 | | | | | 94 - 112 | mmol/L |
| 365 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 132 | | | | | 116 - 164 | g/L |
| 366 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.40 | | | | | 0.34 - 0.48 | |
| 367 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.2 | | | | | 4.1 - 5.6 | TI/L |
| 368 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 369 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 370 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.40 | | | | | 3.8 - 10.7 | GI/L |
| 371 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.63 | | | | | 1.96 - 7.23 | GI/L |
| 372 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.90 | | | | | 0.91 - 4.28 | GI/L |
| 373 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.78 | | | | | 0.12 - 0.92 | GI/L |
| 374 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.05 | | | | | 0 - 0.57 | GI/L |
| 375 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | | 0 - 0.2 | GI/L |
| 376 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 48.8 | | | | | 40.5 - 75 | % |
| 377 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 35.1 | | | | | 15.4 - 48.5 | % |
| 378 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 14.4 | R | H | | | 2.6 - 10.1 | % |
| 379 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 0.9 | | | | | 0 - 6.8 | % |
| 380 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.9 | | | | | 0 - 2 | % |
| 381 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 248 | | | | | 140 - 400 | GI/L |
| 382 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.5 | | | | | <6.5 % | |
| 383 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 2.25 | | | | | 1.9 - 23 | uIU/mL |
| 384 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 385 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.92 | | H | | | 1.03 - 1.53 | mmol/L |
| 386 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | LIPID PANEL | Triglycerides (GPO) | | 1.20 | | | | | 0.59 - 2.96 | mmol/L |
| 387 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | LIPID PANEL | Cholesterol (High Performance) | | 3.66 | | L | | | 4.42 - 7.53 | mmol/L |
| 388 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.19 | | | | | 0 - 3.34 | mmol/L |
| 389 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | RETICULOCYTES | Reticulocyte Count % | | 1.1 | | | | | 0.6 - 2.5 | % |
| 390 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | TSH | TSH 3rd IS-QT | | 3.352 | | | | | 0.45 - 5.33 | mIU/L |
| 391 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Specific Gravity | | 1.023 | | | | | 1 - 1.04 | |
| 392 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur pH | | 5.0 | | | | | 5 - 8 | |
| 393 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 394 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 395 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 396 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 397 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 398 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 399 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 400 | CZ100040009 | | | 58 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 9:50 AM | 6227547338 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 401 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.3 | | | | | 0 - 5 | mg/L |
| 402 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Total Bilirubin | | 10 | | | | | 3 - 21 | umol/L |
| 403 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.5 | | | | | 0 - 6.2 | umol/L |
| 404 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Alkaline Phosphatase | | 137 | | H | | | 35 - 104 | U/L |
| 405 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | ALT (SGPT) | | 11 | | | | | 4 - 43 | U/L |
| 406 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | AST (SGOT) | | 14 | | | | | 8 - 40 | U/L |
| 407 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | GGT | | 14 | | | | | 5 - 50 | U/L |
| 408 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | LDH | | 170 | | | | | 53 - 234 | U/L |
| 409 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Urea Nitrogen | | 5.3 | | | | | 1.4 - 8.6 | mmol/L |
| 410 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 61 | | | | | 31 - 101 | umol/L |
| 411 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Glucose Fasting | | 5.6 | | | | | 3.9 - 5.6 | mmol/L |
| 412 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Serum Uric Acid | | 204 | | | | | 149 - 446 | umol/L |
| 413 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.40 | | | | | 2.07 - 2.64 | mmol/L |
| 414 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Phosphorus | | 0.96 | | | | | 0.71 - 1.65 | mmol/L |
| 415 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Total Protein | | 73 | | | | | 60 - 80 | g/L |
| 416 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 417 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Creatine Kinase | | 78 | | | | | 26 - 192 | U/L |
| 418 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Serum Sodium | | 145 | | | | | 135 - 145 | mmol/L |
| 419 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 420 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.6 | | | | | 19.3 - 29.3 | mmol/L |
| 421 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | CHEMISTRY PANEL | Serum Chloride | | 109 | | | | | 94 - 112 | mmol/L |
| 422 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 150 | | | | | 115 - 158 | g/L |
| 423 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.47 | | | | | 0.34 - 0.48 | |
| 424 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.9 | | | | | 3.9 - 5.5 | TI/L |
| 425 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 426 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 80 - 100 | fL |
| 427 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 7.17 | | | | | 3.8 - 10.7 | GI/L |
| 428 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.80 | | | | | 1.96 - 7.23 | GI/L |
| 429 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.79 | | | | | 0.8 - 3 | GI/L |
| 430 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.41 | | | | | 0.12 - 0.92 | GI/L |
| 431 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.08 | | | | | 0 - 0.57 | GI/L |
| 432 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.09 | | | | | 0 - 0.2 | GI/L |
| 433 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 53.0 | | | | | 40.5 - 75 | % |
| 434 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 38.9 | | | | | 15.4 - 48.5 | % |
| 435 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.8 | | | | | 2.6 - 10.1 | % |
| 436 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.1 | | | | | 0 - 6.8 | % |
| 437 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.3 | | | | | 0 - 2 | % |
| 438 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 239 | | | | | 130 - 394 | GI/L |
| 439 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.5 | | | | | <6.5 % | |
| 440 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 4.88 | | | | | 1.9 - 23 | uIU/mL |
| 441 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 442 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.85 | | H | | | 1.03 - 1.53 | mmol/L |
| 443 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | LIPID PANEL | Triglycerides (GPO) | | 0.61 | | L | | | 0.63 - 2.71 | mmol/L |
| 444 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | LIPID PANEL | Cholesterol (High Performance) | | 5.06 | | | | | 4.86 - 8.28 | mmol/L |
| 445 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.93 | | | | | 0 - 3.34 | mmol/L |
| 446 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | RETICULOCYTES | Reticulocyte Count % | | 1.1 | | | | | 0.6 - 2.5 | % |
| 447 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | TSH | TSH 3rd IS-QT | | 0.955 | | | | | 0.45 - 5.33 | mIU/L |
| 448 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Specific Gravity | | 1.025 | | | | | 1.01 - 1.03 | |
| 449 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 450 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 451 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 452 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 453 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 454 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 455 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 456 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 457 | CZ100040008 | | | 63 | years | Female | End of Phase/Treatment | | May 5, 2026 8:45 AM | 6227768458 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 458 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 4.2 | | | | | 0 - 5 | mg/L |
| 459 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 460 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.0 | | | | | 0 - 6.2 | umol/L |
| 461 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Alkaline Phosphatase | | 62 | | | | | 35 - 104 | U/L |
| 462 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | ALT (SGPT) | | 14 | | | | | 4 - 43 | U/L |
| 463 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | AST (SGOT) | | 19 | | | | | 8 - 40 | U/L |
| 464 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | GGT | | 16 | | | | | 5 - 50 | U/L |
| 465 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | LDH | | | | | Test cancelled: Hemolysis-test not performed | | | |
| 466 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Urea Nitrogen | | 4.3 | | | | | 1.4 - 8.6 | mmol/L |
| 467 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 64 | | | | | 31 - 101 | umol/L |
| 468 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Glucose Fasting | | 5.8 | | H | | | 3.9 - 5.6 | mmol/L |
| 469 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Serum Uric Acid | | 216 | | | | | 149 - 446 | umol/L |
| 470 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 471 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Phosphorus | | 1.09 | | | | | 0.71 - 1.65 | mmol/L |
| 472 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Total Protein | | 63 | | | | | 60 - 80 | g/L |
| 473 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Albumin-BCG | | 42 | | | | | 33 - 49 | g/L |
| 474 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Creatine Kinase | | 151 | | | | | 26 - 192 | U/L |
| 475 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Serum Sodium | | 142 | | | | | 135 - 145 | mmol/L |
| 476 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Serum Potassium | | 4.4 | | | | | 3.5 - 5.2 | mmol/L |
| 477 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.4 | | | | | 19.3 - 29.3 | mmol/L |
| 478 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | CHEMISTRY PANEL | Serum Chloride | | 108 | | | | | 94 - 112 | mmol/L |
| 479 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 152 | | | | | 115 - 158 | g/L |
| 480 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.46 | | | | | 0.34 - 0.48 | |
| 481 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.6 | | | | | 3.9 - 5.5 | TI/L |
| 482 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 483 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 100 | | | | | 80 - 100 | fL |
| 484 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 7.94 | | | | | 3.8 - 10.7 | GI/L |
| 485 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.03 | | | | | 1.96 - 7.23 | GI/L |
| 486 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.45 | | | | | 0.8 - 3 | GI/L |
| 487 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.32 | | | | | 0.12 - 0.92 | GI/L |
| 488 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.10 | | | | | 0 - 0.57 | GI/L |
| 489 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.04 | | | | | 0 - 0.2 | GI/L |
| 490 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 75.9 | R | H | | | 40.5 - 75 | % |
| 491 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 18.3 | | | | | 15.4 - 48.5 | % |
| 492 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 4.0 | | | | | 2.6 - 10.1 | % |
| 493 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.3 | | | | | 0 - 6.8 | % |
| 494 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 495 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 244 | | | | | 130 - 394 | GI/L |
| 496 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.4 | | | | | <6.5 % | |
| 497 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 7.00 | | | | | 1.9 - 23 | uIU/mL |
| 498 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 499 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.24 | | | | | 1.03 - 1.53 | mmol/L |
| 500 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | LIPID PANEL | Triglycerides (GPO) | | 0.74 | | | | | 0.63 - 2.71 | mmol/L |
| 501 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | LIPID PANEL | Cholesterol (High Performance) | | 4.25 | | L | | | 4.86 - 8.28 | mmol/L |
| 502 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.67 | | | | | 0 - 3.34 | mmol/L |
| 503 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | RETICULOCYTES | Reticulocyte Count % | | 1.0 | | | | | 0.6 - 2.5 | % |
| 504 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | TSH | TSH 3rd IS-QT | | 1.798 | | | | | 0.45 - 5.33 | mIU/L |
| 505 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Specific Gravity | | 1.016 | | | | | 1.01 - 1.03 | |
| 506 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 507 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 508 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 509 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 510 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 511 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 512 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 513 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 514 | CZ100040007 | | | 66 | years | Female | Part 2 OL Induction Baseline | | May 5, 2026 7:50 AM | 6227541256 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 515 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 0.9 | | | | | 0 - 5 | mg/L |
| 516 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Total Bilirubin | | 11 | | | | | 3 - 21 | umol/L |
| 517 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.4 | | | | | 0 - 6.2 | umol/L |
| 518 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Alkaline Phosphatase | | 81 | | | | | 35 - 104 | U/L |
| 519 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | ALT (SGPT) | | 23 | | | | | 4 - 43 | U/L |
| 520 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | AST (SGOT) | | 19 | | | | | 8 - 40 | U/L |
| 521 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | GGT | | 19 | | | | | 4 - 49 | U/L |
| 522 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | LDH | | 193 | | | | | 53 - 234 | U/L |
| 523 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Urea Nitrogen | | 4.7 | | | | | 1.4 - 8.6 | mmol/L |
| 524 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 72 | | | | | 31 - 101 | umol/L |
| 525 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 526 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Serum Uric Acid | | 206 | | | | | 149 - 446 | umol/L |
| 527 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.43 | | | | | 2.07 - 2.64 | mmol/L |
| 528 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Phosphorus | | 1.36 | | | | | 0.71 - 1.65 | mmol/L |
| 529 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Total Protein | | 65 | | | | | 61 - 84 | g/L |
| 530 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 531 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Creatine Kinase | | 82 | | | | | 26 - 192 | U/L |
| 532 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Serum Sodium | | 145 | | | | | 132 - 147 | mmol/L |
| 533 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Serum Potassium | | 4.3 | | | | | 3.5 - 5.2 | mmol/L |
| 534 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.9 | | | | | 19.3 - 29.3 | mmol/L |
| 535 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | CHEMISTRY PANEL | Serum Chloride | | 105 | | | | | 94 - 112 | mmol/L |
| 536 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 139 | | | | | 116 - 164 | g/L |
| 537 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.43 | | | | | 0.34 - 0.48 | |
| 538 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.5 | | | | | 4.1 - 5.6 | TI/L |
| 539 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 540 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 541 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.84 | | | | | 3.8 - 10.7 | GI/L |
| 542 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.66 | | | | | 1.96 - 7.23 | GI/L |
| 543 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.78 | | | | | 0.91 - 4.28 | GI/L |
| 544 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.27 | | | | | 0.12 - 0.92 | GI/L |
| 545 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.08 | | | | | 0 - 0.57 | GI/L |
| 546 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.04 | | | | | 0 - 0.2 | GI/L |
| 547 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 55.0 | | | | | 40.5 - 75 | % |
| 548 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 36.8 | | | | | 15.4 - 48.5 | % |
| 549 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.7 | | | | | 2.6 - 10.1 | % |
| 550 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.7 | | | | | 0 - 6.8 | % |
| 551 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.8 | | | | | 0 - 2 | % |
| 552 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 274 | | | | | 140 - 400 | GI/L |
| 553 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.1 | | | | | <6.5 % | |
| 554 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.31 | | | | | 1.9 - 23 | uIU/mL |
| 555 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 556 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.64 | | H | | | 1.03 - 1.53 | mmol/L |
| 557 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | LIPID PANEL | Triglycerides (GPO) | | 0.68 | | | | | 0.59 - 2.96 | mmol/L |
| 558 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | LIPID PANEL | Cholesterol (High Performance) | | 5.02 | | | | | 4.42 - 7.53 | mmol/L |
| 559 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.07 | | | | | 0 - 3.34 | mmol/L |
| 560 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | RETICULOCYTES | Reticulocyte Count % | | 0.9 | | | | | 0.6 - 2.5 | % |
| 561 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | TSH | TSH 3rd IS-QT | | 1.896 | | | | | 0.45 - 5.33 | mIU/L |
| 562 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Specific Gravity | | 1.022 | | | | | 1 - 1.04 | |
| 563 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur pH | | 6.5 | | | | | 5 - 8 | |
| 564 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 565 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 566 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 567 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 568 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 569 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 570 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 571 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | May 5, 2026 7:15 AM | 6227178910 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 572 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.6 | | | | | 0 - 5 | mg/L |
| 573 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Total Bilirubin | | <3 | | L | | Result verified by repeat analysis | 3 - 21 | umol/L |
| 574 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | <1.4 | | | | | 0 - 6.2 | umol/L |
| 575 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Alkaline Phosphatase | | 88 | | | | | 35 - 104 | U/L |
| 576 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | ALT (SGPT) | | 24 | | | | | 4 - 43 | U/L |
| 577 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | AST (SGOT) | | 21 | | | | | 8 - 40 | U/L |
| 578 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | GGT | | 32 | | | | | 4 - 49 | U/L |
| 579 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | LDH | | 156 | | | | | 53 - 234 | U/L |
| 580 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Urea Nitrogen | | 4.0 | | | | | 1.4 - 8.6 | mmol/L |
| 581 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 39 | | | | | 31 - 101 | umol/L |
| 582 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Glucose Fasting | | 5.0 | | | | | 3.9 - 5.6 | mmol/L |
| 583 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Serum Uric Acid | | 335 | | | | | 125 - 428 | umol/L |
| 584 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.12 | | | | | 2.07 - 2.64 | mmol/L |
| 585 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Phosphorus | | 1.07 | | | | | 0.71 - 1.65 | mmol/L |
| 586 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Total Protein | | 66 | | | | | 61 - 84 | g/L |
| 587 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Albumin-BCG | | 39 | | | | | 33 - 49 | g/L |
| 588 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Creatine Kinase | | 135 | | | | | 26 - 192 | U/L |
| 589 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Serum Sodium | | 142 | | | | | 132 - 147 | mmol/L |
| 590 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Serum Potassium | | 4.1 | | | | | 3.5 - 5.2 | mmol/L |
| 591 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Serum Bicarbonate | | 20.2 | | | | | 19.3 - 29.3 | mmol/L |
| 592 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | CHEMISTRY PANEL | Serum Chloride | | 109 | | | | | 94 - 112 | mmol/L |
| 593 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | DIRECT LDL | Direct LDL-C 3rd Gen | | 3.40 | | H | | | <3.36 mmol/L | |
| 594 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 145 | | | | | 116 - 164 | g/L |
| 595 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.44 | | | | | 0.34 - 0.48 | |
| 596 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.5 | | | | | 4.1 - 5.6 | TI/L |
| 597 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 598 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 599 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 11.75 | | H | | | 3.8 - 10.7 | GI/L |
| 600 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.71 | | | | | 1.96 - 7.23 | GI/L |
| 601 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 4.08 | | | | | 0.91 - 4.28 | GI/L |
| 602 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.60 | | | | | 0.12 - 0.92 | GI/L |
| 603 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.24 | | | | | 0 - 0.57 | GI/L |
| 604 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.11 | | | | | 0 - 0.2 | GI/L |
| 605 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 57.1 | | | | | 40.5 - 75 | % |
| 606 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 34.7 | | | | | 15.4 - 48.5 | % |
| 607 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.1 | | | | | 2.6 - 10.1 | % |
| 608 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.1 | | | | | 0 - 6.8 | % |
| 609 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.9 | | | | | 0 - 2 | % |
| 610 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 550 | | H | | | 140 - 400 | GI/L |
| 611 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 6.7 | R | H | | | <6.5 % | |
| 612 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 73.67 | R | H | | | 1.9 - 23 | uIU/mL |
| 613 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 614 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.00 | | L | | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L |
| 615 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | LIPID PANEL | Triglycerides (GPO) | | 5.91 | | H SF | | | 0.51 - 2.42 | mmol/L |
| 616 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | LIPID PANEL | Cholesterol (High Performance) | | 5.54 | | | | | 4.01 - 6.85 | mmol/L |
| 617 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | LIPID PANEL | LDL Chol Friedewald 4th | | | | | Test cancelled: Invalid/High Triglycerides | | | |
| 618 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | RETICULOCYTES | Reticulocyte Count % | | 1.7 | | | | | 0.6 - 2.5 | % |
| 619 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | TSH | TSH 3rd IS-QT | | 2.578 | | | | | 0.45 - 5.33 | mIU/L |
| 620 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Specific Gravity | | 1.006 | | | | | 1 - 1.04 | |
| 621 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 622 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 623 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 624 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 625 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 626 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 627 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 628 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 629 | CZ100040006 | | | 48 | years | Female | Part 2 OL Induction Baseline | | Apr 10, 2026 11:15 AM | 6227547337 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 630 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.7 | | | | | 0 - 5 | mg/L |
| 631 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Total Bilirubin | | 7 | | | | | 3 - 21 | umol/L |
| 632 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.8 | | | | | 0 - 6.2 | umol/L |
| 633 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Alkaline Phosphatase | | 69 | | | | | 35 - 104 | U/L |
| 634 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | ALT (SGPT) | | 25 | | | | | 4 - 43 | U/L |
| 635 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | AST (SGOT) | | 36 | | | | | 8 - 40 | U/L |
| 636 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | GGT | | 43 | | | | | 4 - 49 | U/L |
| 637 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | LDH | | 193 | | | | | 53 - 234 | U/L |
| 638 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Urea Nitrogen | | 4.6 | | | | | 1.4 - 8.6 | mmol/L |
| 639 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 65 | | | | | 31 - 101 | umol/L |
| 640 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Glucose Fasting | | 4.8 | | | | | 3.9 - 5.6 | mmol/L |
| 641 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Serum Uric Acid | | 321 | | | | | 149 - 446 | umol/L |
| 642 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.13 | | | | | 2.07 - 2.64 | mmol/L |
| 643 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Phosphorus | | 0.91 | | | | | 0.71 - 1.65 | mmol/L |
| 644 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Total Protein | | 65 | | | | | 61 - 84 | g/L |
| 645 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Albumin-BCG | | 42 | | | | | 33 - 49 | g/L |
| 646 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Creatine Kinase | | 93 | | | | | 26 - 192 | U/L |
| 647 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Serum Sodium | | 142 | | | | | 132 - 147 | mmol/L |
| 648 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Serum Potassium | | 3.7 | | | | | 3.5 - 5.2 | mmol/L |
| 649 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.6 | | | | | 19.3 - 29.3 | mmol/L |
| 650 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CHEMISTRY PANEL | Serum Chloride | | 107 | | | | | 94 - 112 | mmol/L |
| 651 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.65 | | | | | 1.25 - 1.92 | mL/sec |
| 652 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 65 | | | | | 31 - 101 | umol/L |
| 653 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 75.1 | | | | | kg | |
| 654 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 655 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 656 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 657 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 658 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 659 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 660 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 661 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | | | | | | |
| 662 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | GFR | EGFR by MDRD | | 81 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 663 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 134 | | | | | 116 - 164 | g/L |
| 664 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.40 | | | | | 0.34 - 0.48 | |
| 665 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.2 | | | | | 4.1 - 5.6 | TI/L |
| 666 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 667 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 668 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.08 | | | | | 3.8 - 10.7 | GI/L |
| 669 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.60 | | | | | 1.96 - 7.23 | GI/L |
| 670 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.79 | | | | | 0.91 - 4.28 | GI/L |
| 671 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.52 | | | | | 0.12 - 0.92 | GI/L |
| 672 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.12 | | | | | 0 - 0.57 | GI/L |
| 673 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | | 0 - 0.2 | GI/L |
| 674 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 51.1 | | | | | 40.5 - 75 | % |
| 675 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 35.3 | | | | | 15.4 - 48.5 | % |
| 676 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 10.2 | R | H | | | 2.6 - 10.1 | % |
| 677 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.4 | | | | | 0 - 6.8 | % |
| 678 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.9 | | | | | 0 - 2 | % |
| 679 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 267 | | | | | 140 - 400 | GI/L |
| 680 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.5 | | | | | <6.5 % | |
| 681 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 4.13 | | | | | 1.9 - 23 | uIU/mL |
| 682 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 683 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 684 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | LIPID PANEL | Direct HDL-C 4th Generation | | 2.21 | | H | | | 1.03 - 1.53 | mmol/L |
| 685 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | LIPID PANEL | Triglycerides (GPO) | | 0.81 | | | | | 0.59 - 2.96 | mmol/L |
| 686 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | LIPID PANEL | Cholesterol (High Performance) | | 3.95 | | L | | | 4.42 - 7.53 | mmol/L |
| 687 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.37 | | | | | 0 - 3.34 | mmol/L |
| 688 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | No | | | | | | |
| 689 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | RETICULOCYTES | Reticulocyte Count % | | 1.4 | | | | | 0.6 - 2.5 | % |
| 690 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | TSH | TSH 3rd IS-QT | | 3.004 | | | | | 0.45 - 5.33 | mIU/L |
| 691 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Specific Gravity | | 1.020 | | | | | 1 - 1.04 | |
| 692 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 693 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 694 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 695 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 696 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 697 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 698 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 699 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 700 | CZ100040009 | | | 58 | years | Female | Part 2 Screening | | Apr 10, 2026 8:15 AM | 6227547336 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 701 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 3.0 | | | | | 0 - 5 | mg/L |
| 702 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 703 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | <1.4 | | | | | 0 - 6.2 | umol/L |
| 704 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Alkaline Phosphatase | | 94 | | | | | 35 - 104 | U/L |
| 705 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | ALT (SGPT) | | 17 | | | | | 4 - 43 | U/L |
| 706 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | AST (SGOT) | | 19 | | | | | 8 - 40 | U/L |
| 707 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | GGT | | 17 | | | | | 5 - 50 | U/L |
| 708 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | LDH | | 163 | | | | | 53 - 234 | U/L |
| 709 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Urea Nitrogen | | 4.3 | | | | | 1.4 - 10.4 | mmol/L |
| 710 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 68 | | | | | 31 - 110 | umol/L |
| 711 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Glucose Fasting | | 5.4 | | | | | 3.9 - 5.6 | mmol/L |
| 712 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Serum Uric Acid | | 265 | | | | | 149 - 446 | umol/L |
| 713 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 714 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Phosphorus | | 1.45 | | | | | 0.71 - 1.65 | mmol/L |
| 715 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Total Protein | | 78 | | | | | 60 - 80 | g/L |
| 716 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Albumin-BCG | | 47 | R | H | | | 33 - 46 | g/L |
| 717 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Creatine Kinase | | 80 | | | | | 26 - 192 | U/L |
| 718 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Serum Sodium | | 137 | | | | | 135 - 145 | mmol/L |
| 719 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Serum Potassium | | 4.6 | | | | | 3.5 - 5.2 | mmol/L |
| 720 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.7 | | | | | 19.3 - 29.3 | mmol/L |
| 721 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 722 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 159 | R | H | | | 115 - 158 | g/L |
| 723 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.47 | | | | | 0.34 - 0.48 | |
| 724 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.1 | | | | | 3.9 - 5.5 | TI/L |
| 725 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 726 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 93 | | | | | 80 - 100 | fL |
| 727 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 9.76 | | | | | 3.8 - 10.7 | GI/L |
| 728 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 5.09 | | | | | 1.96 - 7.23 | GI/L |
| 729 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.77 | R | H | | | 0.8 - 3 | GI/L |
| 730 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.73 | | | | | 0.12 - 0.92 | GI/L |
| 731 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.11 | | | | | 0 - 0.57 | GI/L |
| 732 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.07 | | | | | 0 - 0.2 | GI/L |
| 733 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 52.1 | | | | | 40.5 - 75 | % |
| 734 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 38.6 | | | | | 15.4 - 48.5 | % |
| 735 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 7.5 | | | | | 2.6 - 10.1 | % |
| 736 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.2 | | | | | 0 - 6.8 | % |
| 737 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.7 | | | | | 0 - 2 | % |
| 738 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 307 | | | | | 130 - 394 | GI/L |
| 739 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.8 | | | | | <6.5 % | |
| 740 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | | | | Test cancelled: Hemolysis-test not performed | | | |
| 741 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 742 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.36 | | | | | 1.03 - 1.53 | mmol/L |
| 743 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | LIPID PANEL | Triglycerides (GPO) | | 3.03 | | H | | | 0.63 - 2.71 | mmol/L |
| 744 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | LIPID PANEL | Cholesterol (High Performance) | | 7.15 | | | | | 5.35 - 9.1 | mmol/L |
| 745 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.40 | | H | | | 0 - 3.34 | mmol/L |
| 746 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | RETICULOCYTES | Reticulocyte Count % | | 1.6 | | | | | 0.6 - 2.5 | % |
| 747 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | TSH | TSH 3rd IS-QT | | 1.854 | | | | | 0.45 - 5.33 | mIU/L |
| 748 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Specific Gravity | | 1.012 | | | | | 1.01 - 1.03 | |
| 749 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur pH | | 5.0 | | | | | 5 - 8 | |
| 750 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 751 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 752 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 753 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 754 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 755 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 756 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 757 | CZ100040005 | | | 72 | years | Female | Part 2 OL Induction Baseline | | Apr 7, 2026 9:45 AM | 6227541258 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 758 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.3 | | | | | 0 - 5 | mg/L |
| 759 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 760 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.6 | | | | | 0 - 6.2 | umol/L |
| 761 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Alkaline Phosphatase | | 100 | | | | | 35 - 104 | U/L |
| 762 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | ALT (SGPT) | | 30 | | | | | 4 - 43 | U/L |
| 763 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | AST (SGOT) | | 27 | | | | | 8 - 40 | U/L |
| 764 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | GGT | | 18 | | | | | 4 - 49 | U/L |
| 765 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | LDH | | 235 | | H | | | 53 - 234 | U/L |
| 766 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Urea Nitrogen | | 5.4 | | | | | 1.4 - 8.6 | mmol/L |
| 767 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 76 | | | | | 31 - 101 | umol/L |
| 768 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Glucose Fasting | | 4.7 | | | | | 3.9 - 5.6 | mmol/L |
| 769 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Serum Uric Acid | | 308 | | | | | 149 - 446 | umol/L |
| 770 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.33 | | | | | 2.07 - 2.64 | mmol/L |
| 771 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Phosphorus | | 1.09 | | | | | 0.71 - 1.65 | mmol/L |
| 772 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Total Protein | | 71 | | | | | 61 - 84 | g/L |
| 773 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 774 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Creatine Kinase | | 119 | | | | | 26 - 192 | U/L |
| 775 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 776 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Serum Potassium | | 4.2 | | | | | 3.5 - 5.2 | mmol/L |
| 777 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Serum Bicarbonate | | 24.5 | | | | | 19.3 - 29.3 | mmol/L |
| 778 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | CHEMISTRY PANEL | Serum Chloride | | 101 | | | | | 94 - 112 | mmol/L |
| 779 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 143 | | | | | 116 - 164 | g/L |
| 780 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 781 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.8 | | | | | 4.1 - 5.6 | TI/L |
| 782 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | Normocytic | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 783 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 89 | | | | | 79 - 98 | fL |
| 784 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.03 | | | | | 3.8 - 10.7 | GI/L |
| 785 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.95 | | | | | 1.96 - 7.23 | GI/L |
| 786 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.62 | | | | | 0.91 - 4.28 | GI/L |
| 787 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.32 | | | | | 0.12 - 0.92 | GI/L |
| 788 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.13 | | | | | 0 - 0.57 | GI/L |
| 789 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.02 | | | | | 0 - 0.2 | GI/L |
| 790 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.6 | | | | | 40.5 - 75 | % |
| 791 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 32.2 | | | | | 15.4 - 48.5 | % |
| 792 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.3 | | | | | 2.6 - 10.1 | % |
| 793 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.5 | | | | | 0 - 6.8 | % |
| 794 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.4 | | | | | 0 - 2 | % |
| 795 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | | | | Test cancelled: Platelet clumps present | | | |
| 796 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.6 | | | | | <6.5 % | |
| 797 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 8.28 | | | | | 1.9 - 23 | uIU/mL |
| 798 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 799 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.34 | | | | | 1.03 - 1.53 | mmol/L |
| 800 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | LIPID PANEL | Triglycerides (GPO) | | 1.17 | | | | | 0.59 - 2.96 | mmol/L |
| 801 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | LIPID PANEL | Cholesterol (High Performance) | | 6.97 | | | | | 4.42 - 7.53 | mmol/L |
| 802 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | LIPID PANEL | LDL Chol Friedewald 4th | | 5.09 | | H | | | 0 - 3.34 | mmol/L |
| 803 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | RETICULOCYTES | Reticulocyte Count % | | 1.7 | | | | | 0.6 - 2.5 | % |
| 804 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | TSH | TSH 3rd IS-QT | | | | | Test group cancelled: No specimen received | | | |
| 805 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Specific Gravity | | 1.022 | | | | | 1 - 1.04 | |
| 806 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 807 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 808 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 809 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 810 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 811 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 812 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 813 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 814 | CZ100040001 | | | 56 | years | Female | Part 2 DB Week 13 | | Apr 7, 2026 8:35 AM | 6227541264 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 815 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.8 | | | | | 0 - 5 | mg/L |
| 816 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CELLULAR ELEMENTS | Ur WBC/HPF | | 7 | | | | | 0 - 12 | /HPF |
| 817 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Total Bilirubin | | 14 | | | | | 3 - 21 | umol/L |
| 818 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 5.1 | | | | | 0 - 6.2 | umol/L |
| 819 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Alkaline Phosphatase | | 86 | | | | | 35 - 104 | U/L |
| 820 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | ALT (SGPT) | | 61 | R | H | | | 4 - 43 | U/L |
| 821 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | AST (SGOT) | | 37 | | | | | 8 - 40 | U/L |
| 822 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | GGT | | 25 | | | | | 4 - 49 | U/L |
| 823 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | LDH | | 181 | | | | | 53 - 234 | U/L |
| 824 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Urea Nitrogen | | 4.3 | | | | | 1.4 - 8.6 | mmol/L |
| 825 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 75 | | | | | 31 - 101 | umol/L |
| 826 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Glucose Fasting | | 6.1 | R | H | | | 3.9 - 5.6 | mmol/L |
| 827 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Serum Uric Acid | | 287 | | | | | 149 - 446 | umol/L |
| 828 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.34 | | | | | 2.07 - 2.64 | mmol/L |
| 829 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Phosphorus | | 1.16 | | | | | 0.71 - 1.65 | mmol/L |
| 830 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Total Protein | | 64 | | | | | 61 - 84 | g/L |
| 831 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Albumin-BCG | | 44 | | | | | 33 - 49 | g/L |
| 832 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Creatine Kinase | | 52 | | | | | 26 - 192 | U/L |
| 833 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 132 - 147 | mmol/L |
| 834 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Serum Potassium | | 4.3 | | | | | 3.5 - 5.2 | mmol/L |
| 835 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.7 | | | | | 19.3 - 29.3 | mmol/L |
| 836 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | CHEMISTRY PANEL | Serum Chloride | | 104 | | | | | 94 - 112 | mmol/L |
| 837 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 151 | | | | | 116 - 164 | g/L |
| 838 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.45 | | | | | 0.34 - 0.48 | |
| 839 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.0 | | | | | 4.1 - 5.6 | TI/L |
| 840 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 841 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 91 | | | | | 79 - 98 | fL |
| 842 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 7.52 | | | | | 3.8 - 10.7 | GI/L |
| 843 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.64 | | | | | 1.96 - 7.23 | GI/L |
| 844 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.27 | | | | | 0.91 - 4.28 | GI/L |
| 845 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.38 | | | | | 0.12 - 0.92 | GI/L |
| 846 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 847 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.08 | | | | | 0 - 0.2 | GI/L |
| 848 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 61.7 | | | | | 40.5 - 75 | % |
| 849 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 30.2 | | | | | 15.4 - 48.5 | % |
| 850 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.0 | | | | | 2.6 - 10.1 | % |
| 851 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.0 | | | | | 0 - 6.8 | % |
| 852 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.0 | | | | | 0 - 2 | % |
| 853 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 310 | | | | | 140 - 400 | GI/L |
| 854 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 6.4 | | | | | <6.5 % | |
| 855 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 18.47 | | | | | 1.9 - 23 | uIU/mL |
| 856 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 857 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | LIPID PANEL | Direct HDL-C 4th Generation | | 0.95 | R | L | | | 1.03 - 1.53 | mmol/L |
| 858 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | LIPID PANEL | Triglycerides (GPO) | | 1.13 | | | | | 0.59 - 2.96 | mmol/L |
| 859 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | LIPID PANEL | Cholesterol (High Performance) | | 2.38 | | L | | Result verified by repeat analysis | 4.42 - 7.53 | mmol/L |
| 860 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | LIPID PANEL | LDL Chol Friedewald 4th | | 0.91 | | | | | 0 - 3.34 | mmol/L |
| 861 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | RETICULOCYTES | Reticulocyte Count % | | 2.0 | | | | | 0.6 - 2.5 | % |
| 862 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | TSH | TSH 3rd IS-QT | | 0.827 | | | | | 0.45 - 5.33 | mIU/L |
| 863 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Specific Gravity | | 1.019 | | | | | 1 - 1.04 | |
| 864 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 865 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 866 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 867 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 868 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 869 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 870 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 871 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 872 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +2 | | H SF | | | Ref Rng:Negative | |
| 873 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Mar 27, 2026 10:00 AM | 6227768460 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 874 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.7 | | | | | 0 - 5 | mg/L |
| 875 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Total Bilirubin | | 19 | | | | | 3 - 21 | umol/L |
| 876 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 5.6 | | | | | 0 - 6.2 | umol/L |
| 877 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Alkaline Phosphatase | | 122 | | H | | | 35 - 104 | U/L |
| 878 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | ALT (SGPT) | | 9 | | | | | 4 - 43 | U/L |
| 879 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | AST (SGOT) | | 15 | | | | | 8 - 40 | U/L |
| 880 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | GGT | | 12 | | | | | 5 - 50 | U/L |
| 881 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | LDH | | 154 | | | | | 53 - 234 | U/L |
| 882 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Urea Nitrogen | | 6.0 | | | | | 1.4 - 8.6 | mmol/L |
| 883 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 65 | | | | | 31 - 101 | umol/L |
| 884 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Glucose Fasting | | 6.3 | | H | | | 3.9 - 5.6 | mmol/L |
| 885 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Serum Uric Acid | | 223 | | | | | 149 - 446 | umol/L |
| 886 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.31 | | | | | 2.07 - 2.64 | mmol/L |
| 887 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Phosphorus | | 0.91 | | | | | 0.71 - 1.65 | mmol/L |
| 888 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Total Protein | | 68 | | | | | 60 - 80 | g/L |
| 889 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Albumin-BCG | | 44 | | | | | 33 - 49 | g/L |
| 890 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Creatine Kinase | | 85 | | | | | 26 - 192 | U/L |
| 891 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 135 - 145 | mmol/L |
| 892 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Serum Potassium | | 4.3 | | | | | 3.5 - 5.2 | mmol/L |
| 893 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.4 | | | | | 19.3 - 29.3 | mmol/L |
| 894 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | CHEMISTRY PANEL | Serum Chloride | | 106 | | | | | 94 - 112 | mmol/L |
| 895 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 147 | | | | | 115 - 158 | g/L |
| 896 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.45 | | | | | 0.34 - 0.48 | |
| 897 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.7 | | | | | 3.9 - 5.5 | TI/L |
| 898 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 899 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 94 | | | | | 80 - 100 | fL |
| 900 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 6.41 | | | | | 3.8 - 10.7 | GI/L |
| 901 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.51 | | | | | 1.96 - 7.23 | GI/L |
| 902 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.33 | | | | | 0.8 - 3 | GI/L |
| 903 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.35 | | | | | 0.12 - 0.92 | GI/L |
| 904 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.13 | | | | | 0 - 0.57 | GI/L |
| 905 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.09 | | | | | 0 - 0.2 | GI/L |
| 906 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 54.7 | | | | | 40.5 - 75 | % |
| 907 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 36.2 | | | | | 15.4 - 48.5 | % |
| 908 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.5 | | | | | 2.6 - 10.1 | % |
| 909 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.1 | | | | | 0 - 6.8 | % |
| 910 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.4 | | | | | 0 - 2 | % |
| 911 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 232 | | | | | 130 - 394 | GI/L |
| 912 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 4.38 | | | | | 1.9 - 23 | uIU/mL |
| 913 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 914 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.74 | R | H | | | 1.03 - 1.53 | mmol/L |
| 915 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | LIPID PANEL | Triglycerides (GPO) | | 0.57 | R | L | | | 0.63 - 2.71 | mmol/L |
| 916 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | LIPID PANEL | Cholesterol (High Performance) | | 4.75 | R | L | | | 4.86 - 8.28 | mmol/L |
| 917 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.75 | | | | | 0 - 3.34 | mmol/L |
| 918 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | RETICULOCYTES | Reticulocyte Count % | | 0.9 | | | | | 0.6 - 2.5 | % |
| 919 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Specific Gravity | | 1.006 | | | | | 1.01 - 1.03 | |
| 920 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 921 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 922 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 923 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 924 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 925 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 926 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 927 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 928 | CZ100040008 | | | 63 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 8:45 AM | 6227547333 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 929 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 8.5 | R | H | | | 0 - 5 | mg/L |
| 930 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 931 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.3 | | | | | 0 - 6.2 | umol/L |
| 932 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Alkaline Phosphatase | | 61 | | | | | 35 - 104 | U/L |
| 933 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | ALT (SGPT) | | 15 | | | | | 4 - 43 | U/L |
| 934 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | AST (SGOT) | | 17 | | | | | 8 - 40 | U/L |
| 935 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | GGT | | 14 | | | | | 5 - 50 | U/L |
| 936 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | LDH | | 150 | | | | | 53 - 234 | U/L |
| 937 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Urea Nitrogen | | 4.4 | | | | | 1.4 - 8.6 | mmol/L |
| 938 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 56 | | | | | 31 - 101 | umol/L |
| 939 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Glucose Fasting | | 5.7 | | H | | | 3.9 - 5.6 | mmol/L |
| 940 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Serum Uric Acid | | 207 | | | | | 149 - 446 | umol/L |
| 941 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.32 | | | | | 2.07 - 2.64 | mmol/L |
| 942 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Phosphorus | | 0.89 | | | | | 0.71 - 1.65 | mmol/L |
| 943 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Total Protein | | 63 | | | | | 60 - 80 | g/L |
| 944 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Albumin-BCG | | 41 | | | | | 33 - 49 | g/L |
| 945 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Creatine Kinase | | 78 | | | | | 26 - 192 | U/L |
| 946 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Serum Sodium | | 142 | | | | | 135 - 145 | mmol/L |
| 947 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Serum Potassium | | 4.4 | | | | | 3.5 - 5.2 | mmol/L |
| 948 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.4 | | | | | 19.3 - 29.3 | mmol/L |
| 949 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | CHEMISTRY PANEL | Serum Chloride | | 107 | | | | | 94 - 112 | mmol/L |
| 950 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 149 | | | | | 115 - 158 | g/L |
| 951 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.44 | | | | | 0.34 - 0.48 | |
| 952 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.5 | | | | | 3.9 - 5.5 | TI/L |
| 953 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 954 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 97 | | | | | 80 - 100 | fL |
| 955 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.75 | | | | | 3.8 - 10.7 | GI/L |
| 956 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.15 | | | | | 1.96 - 7.23 | GI/L |
| 957 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.07 | | | | | 0.8 - 3 | GI/L |
| 958 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.38 | | | | | 0.12 - 0.92 | GI/L |
| 959 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.13 | | | | | 0 - 0.57 | GI/L |
| 960 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.02 | | | | | 0 - 0.2 | GI/L |
| 961 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 72.1 | | | | | 40.5 - 75 | % |
| 962 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 18.6 | | | | | 15.4 - 48.5 | % |
| 963 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.7 | | | | | 2.6 - 10.1 | % |
| 964 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.2 | | | | | 0 - 6.8 | % |
| 965 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.4 | | | | | 0 - 2 | % |
| 966 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 234 | | | | | 130 - 394 | GI/L |
| 967 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.19 | | | | | 1.9 - 23 | uIU/mL |
| 968 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 969 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.30 | | | | | 1.03 - 1.53 | mmol/L |
| 970 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | LIPID PANEL | Triglycerides (GPO) | | 0.41 | | L | | | 0.63 - 2.71 | mmol/L |
| 971 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | LIPID PANEL | Cholesterol (High Performance) | | 4.53 | | L | | | 4.86 - 8.28 | mmol/L |
| 972 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.04 | | | | | 0 - 3.34 | mmol/L |
| 973 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | RETICULOCYTES | Reticulocyte Count % | | 1.1 | | | | | 0.6 - 2.5 | % |
| 974 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Specific Gravity | | 1.019 | | | | | 1.01 - 1.03 | |
| 975 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur pH | | 5.0 | | | | | 5 - 8 | |
| 976 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 977 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 978 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 979 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 980 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 981 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 982 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 983 | CZ100040007 | | | 66 | years | Female | Part 1 DB Baseline | | Mar 25, 2026 6:50 AM | 6227541251 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 984 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 0.9 | | | | | 0 - 5 | mg/L |
| 985 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Total Bilirubin | | 11 | | | | | 3 - 21 | umol/L |
| 986 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.0 | | | | | 0 - 6.2 | umol/L |
| 987 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Alkaline Phosphatase | | 78 | | | | | 35 - 104 | U/L |
| 988 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | ALT (SGPT) | | 29 | | | | | 4 - 43 | U/L |
| 989 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | AST (SGOT) | | 24 | | | | | 8 - 40 | U/L |
| 990 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | GGT | | 23 | | | | | 4 - 49 | U/L |
| 991 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | LDH | | 214 | | | | | 53 - 234 | U/L |
| 992 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Urea Nitrogen | | 3.9 | | | | | 1.4 - 8.6 | mmol/L |
| 993 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 80 | | | | | 31 - 101 | umol/L |
| 994 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Glucose Fasting | | 5.4 | | | | | 3.9 - 5.6 | mmol/L |
| 995 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Serum Uric Acid | | 248 | | | | | 149 - 446 | umol/L |
| 996 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 997 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Phosphorus | | 0.93 | | | | | 0.71 - 1.65 | mmol/L |
| 998 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Total Protein | | 64 | | | | | 61 - 84 | g/L |
| 999 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 49 | g/L |
| 1000 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Creatine Kinase | | 128 | | | | | 26 - 192 | U/L |
| 1001 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Serum Sodium | | 142 | | | | | 132 - 147 | mmol/L |
| 1002 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Serum Potassium | | 4.5 | | | | | 3.5 - 5.2 | mmol/L |
| 1003 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.8 | | | | | 19.3 - 29.3 | mmol/L |
| 1004 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | CHEMISTRY PANEL | Serum Chloride | | 105 | | | | | 94 - 112 | mmol/L |
| 1005 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 138 | | | | | 116 - 164 | g/L |
| 1006 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 1007 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.5 | | | | | 4.1 - 5.6 | TI/L |
| 1008 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1009 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 94 | | | | | 79 - 98 | fL |
| 1010 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.44 | | | | | 3.8 - 10.7 | GI/L |
| 1011 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.15 | | | | | 1.96 - 7.23 | GI/L |
| 1012 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.79 | | | | | 0.91 - 4.28 | GI/L |
| 1013 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.33 | | | | | 0.12 - 0.92 | GI/L |
| 1014 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 1015 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.03 | | | | | 0 - 0.2 | GI/L |
| 1016 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 57.9 | | | | | 40.5 - 75 | % |
| 1017 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 32.9 | | | | | 15.4 - 48.5 | % |
| 1018 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.0 | | | | | 2.6 - 10.1 | % |
| 1019 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.7 | | | | | 0 - 6.8 | % |
| 1020 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 1021 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 290 | | | | | 140 - 400 | GI/L |
| 1022 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.1 | | | | | <6.5 % | |
| 1023 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.23 | | | | | 1.9 - 23 | uIU/mL |
| 1024 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1025 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.67 | | H | | | 1.03 - 1.53 | mmol/L |
| 1026 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | LIPID PANEL | Triglycerides (GPO) | | 0.88 | | | | | 0.59 - 2.96 | mmol/L |
| 1027 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | LIPID PANEL | Cholesterol (High Performance) | | 5.28 | | | | | 4.42 - 7.53 | mmol/L |
| 1028 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.21 | | | | | 0 - 3.34 | mmol/L |
| 1029 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | RETICULOCYTES | Reticulocyte Count % | | 1.4 | | | | | 0.6 - 2.5 | % |
| 1030 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | TSH | TSH 3rd IS-QT | | 1.525 | | | | | 0.45 - 5.33 | mIU/L |
| 1031 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Specific Gravity | | 1.019 | | | | | 1 - 1.04 | |
| 1032 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur pH | | 7.0 | | | | | 5 - 8 | |
| 1033 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1034 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1035 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1036 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1037 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1038 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1039 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1040 | CZ100040004 | | | 54 | years | Female | End of Phase/Treatment | | Mar 13, 2026 9:00 AM | 6227768459 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1041 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 4.4 | | | | | 0 - 5 | mg/L |
| 1042 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Total Bilirubin | | 14 | | | | | 3 - 21 | umol/L |
| 1043 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.8 | | | | | 0 - 6.2 | umol/L |
| 1044 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Alkaline Phosphatase | | 81 | | | | | 35 - 104 | U/L |
| 1045 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | ALT (SGPT) | | 25 | | | | | 4 - 43 | U/L |
| 1046 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | AST (SGOT) | | 25 | | | | | 8 - 40 | U/L |
| 1047 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | GGT | | 52 | | H | | | 4 - 49 | U/L |
| 1048 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | LDH | | 153 | | | | | 53 - 234 | U/L |
| 1049 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Urea Nitrogen | | 3.3 | | | | | 1.4 - 8.6 | mmol/L |
| 1050 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 66 | | | | | 31 - 101 | umol/L |
| 1051 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Glucose Fasting | | 5.4 | | | | | 3.9 - 5.6 | mmol/L |
| 1052 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Serum Uric Acid | | 273 | | | | | 125 - 428 | umol/L |
| 1053 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.45 | | | | | 2.07 - 2.64 | mmol/L |
| 1054 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Phosphorus | | 1.02 | | | | | 0.71 - 1.65 | mmol/L |
| 1055 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Total Protein | | 74 | | | | | 61 - 84 | g/L |
| 1056 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 1057 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Creatine Kinase | | 118 | | | | | 26 - 192 | U/L |
| 1058 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Serum Sodium | | 137 | | | | | 132 - 147 | mmol/L |
| 1059 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Serum Potassium | | 4.3 | | | | | 3.5 - 5.2 | mmol/L |
| 1060 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.2 | | | | | 19.3 - 29.3 | mmol/L |
| 1061 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | CHEMISTRY PANEL | Serum Chloride | | 100 | | | | | 94 - 112 | mmol/L |
| 1062 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 131 | | | | | 116 - 164 | g/L |
| 1063 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.39 | | | | | 0.34 - 0.48 | |
| 1064 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.1 | | | | | 4.1 - 5.6 | TI/L |
| 1065 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1066 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 1067 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 6.38 | | | | | 3.8 - 10.7 | GI/L |
| 1068 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.04 | | | | | 1.96 - 7.23 | GI/L |
| 1069 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.60 | | | | | 0.91 - 4.28 | GI/L |
| 1070 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.49 | | | | | 0.12 - 0.92 | GI/L |
| 1071 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.23 | | | | | 0 - 0.57 | GI/L |
| 1072 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.03 | | | | | 0 - 0.2 | GI/L |
| 1073 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 47.6 | | | | | 40.5 - 75 | % |
| 1074 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 40.7 | | | | | 15.4 - 48.5 | % |
| 1075 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 7.6 | | | | | 2.6 - 10.1 | % |
| 1076 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 3.6 | | | | | 0 - 6.8 | % |
| 1077 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 1078 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 315 | | | | | 140 - 400 | GI/L |
| 1079 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.2 | | | | | <6.5 % | |
| 1080 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.83 | | | | | 1.9 - 23 | uIU/mL |
| 1081 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1082 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.70 | | H | | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L |
| 1083 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | LIPID PANEL | Triglycerides (GPO) | | 2.24 | | | | | 0.51 - 2.42 | mmol/L |
| 1084 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | LIPID PANEL | Cholesterol (High Performance) | | 5.71 | | | | | 4.01 - 6.85 | mmol/L |
| 1085 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.98 | | | | | 0 - 3.34 | mmol/L |
| 1086 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | RETICULOCYTES | Reticulocyte Count % | | 1.9 | | | | | 0.6 - 2.5 | % |
| 1087 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | TSH | TSH 3rd IS-QT | | 4.319 | | | | | 0.45 - 5.33 | mIU/L |
| 1088 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Specific Gravity | | 1.021 | | | | | 1 - 1.04 | |
| 1089 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1090 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1091 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1092 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1093 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1094 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1095 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1096 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1097 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Mar 6, 2026 9:50 AM | 6227178911 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1098 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.0 | | | | | 0 - 5 | mg/L |
| 1099 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Total Bilirubin | | 11 | | | | | 3 - 21 | umol/L |
| 1100 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.2 | | | | | 0 - 6.2 | umol/L |
| 1101 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Alkaline Phosphatase | | 130 | | H | | | 35 - 104 | U/L |
| 1102 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | ALT (SGPT) | | 10 | | | | | 4 - 43 | U/L |
| 1103 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | AST (SGOT) | | 14 | | | | | 8 - 40 | U/L |
| 1104 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | GGT | | 13 | | | | | 5 - 50 | U/L |
| 1105 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | LDH | | | | | Test cancelled: Hemolysis-test not performed | | | |
| 1106 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Urea Nitrogen | | 5.6 | | | | | 1.4 - 8.6 | mmol/L |
| 1107 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 63 | | | | | 31 - 101 | umol/L |
| 1108 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Glucose Fasting | | 5.4 | | | | | 3.9 - 5.6 | mmol/L |
| 1109 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Serum Uric Acid | | 232 | | | | | 149 - 446 | umol/L |
| 1110 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.49 | | | | | 2.07 - 2.64 | mmol/L |
| 1111 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Phosphorus | | 0.93 | | | | | 0.71 - 1.65 | mmol/L |
| 1112 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Total Protein | | 73 | | | | | 60 - 80 | g/L |
| 1113 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 49 | g/L |
| 1114 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Creatine Kinase | | 59 | | | | | 26 - 192 | U/L |
| 1115 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 135 - 145 | mmol/L |
| 1116 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Serum Potassium | | 4.2 | | | | | 3.5 - 5.2 | mmol/L |
| 1117 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.2 | | | | | 19.3 - 29.3 | mmol/L |
| 1118 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CHEMISTRY PANEL | Serum Chloride | | 104 | | | | | 94 - 112 | mmol/L |
| 1119 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.61 | | | | | 1.25 - 1.92 | mL/sec |
| 1120 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 63 | | | | | 31 - 101 | umol/L |
| 1121 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 75.5 | | | | | kg | |
| 1122 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 1123 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1124 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 1125 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1126 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1127 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1128 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1129 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | | | | | | |
| 1130 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | FSH | Follicle Stimulating Hormone | | 57.83 | | | | | Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L | |
| 1131 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | GFR | EGFR by MDRD | | 83 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 1132 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 159 | R | H | | | 115 - 158 | g/L |
| 1133 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.49 | R | H | | | 0.34 - 0.48 | |
| 1134 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.2 | | | | | 3.9 - 5.5 | TI/L |
| 1135 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1136 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 93 | | | | | 80 - 100 | fL |
| 1137 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 6.19 | | | | | 3.8 - 10.7 | GI/L |
| 1138 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.31 | | | | | 1.96 - 7.23 | GI/L |
| 1139 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.30 | | | | | 0.8 - 3 | GI/L |
| 1140 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.34 | | | | | 0.12 - 0.92 | GI/L |
| 1141 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.18 | | | | | 0 - 0.57 | GI/L |
| 1142 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.06 | | | | | 0 - 0.2 | GI/L |
| 1143 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 53.5 | | | | | 40.5 - 75 | % |
| 1144 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 37.2 | | | | | 15.4 - 48.5 | % |
| 1145 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.5 | | | | | 2.6 - 10.1 | % |
| 1146 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.9 | | | | | 0 - 6.8 | % |
| 1147 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.0 | | | | | 0 - 2 | % |
| 1148 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 255 | | | | | 130 - 394 | GI/L |
| 1149 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.6 | | | | | <6.5 % | |
| 1150 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 3.27 | | | | | 1.9 - 23 | uIU/mL |
| 1151 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1152 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 1153 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.70 | | H | | | 1.03 - 1.53 | mmol/L |
| 1154 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | LIPID PANEL | Triglycerides (GPO) | | 0.84 | | | | | 0.63 - 2.71 | mmol/L |
| 1155 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | LIPID PANEL | Cholesterol (High Performance) | | 5.60 | | | | | 4.86 - 8.28 | mmol/L |
| 1156 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.52 | | H | | | 0 - 3.34 | mmol/L |
| 1157 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 1158 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | Yes | | | | | | |
| 1159 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | RETICULOCYTES | Reticulocyte Count % | | 1.0 | | | | | 0.6 - 2.5 | % |
| 1160 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | TSH | TSH 3rd IS-QT | | 0.932 | | | | | 0.45 - 5.33 | mIU/L |
| 1161 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Specific Gravity | | 1.006 | | | | | 1.01 - 1.03 | |
| 1162 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1163 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1164 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1165 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1166 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1167 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1168 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1169 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1170 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +1 | | H | | | Ref Rng:Negative | |
| 1171 | CZ100040008 | | | 63 | years | Female | Part 1 Screening | | Mar 6, 2026 9:20 AM | 6227547331 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1172 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.3 | | | | | 0 - 5 | mg/L |
| 1173 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CELLULAR ELEMENTS | Ur WBC/HPF | | 48 | R | H | | | 0 - 12 | /HPF |
| 1174 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Total Bilirubin | | 4 | | | | | 3 - 21 | umol/L |
| 1175 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.6 | | | | | 0 - 6.2 | umol/L |
| 1176 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Alkaline Phosphatase | | 89 | | | | | 35 - 104 | U/L |
| 1177 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | ALT (SGPT) | | 16 | | | | | 4 - 43 | U/L |
| 1178 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | AST (SGOT) | | 17 | | | | | 8 - 40 | U/L |
| 1179 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | GGT | | 28 | | | | | 4 - 49 | U/L |
| 1180 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | LDH | | 141 | | | | | 53 - 234 | U/L |
| 1181 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Urea Nitrogen | | 4.6 | | | | | 1.4 - 8.6 | mmol/L |
| 1182 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 52 | | | | | 31 - 101 | umol/L |
| 1183 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Glucose Fasting | | 6.7 | R | H | | | 3.9 - 5.6 | mmol/L |
| 1184 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Serum Uric Acid | | 325 | | | | | 125 - 428 | umol/L |
| 1185 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.52 | | | | | 2.07 - 2.64 | mmol/L |
| 1186 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Phosphorus | | 1.23 | | | | | 0.71 - 1.65 | mmol/L |
| 1187 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Total Protein | | 75 | | | | | 61 - 84 | g/L |
| 1188 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 1189 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Creatine Kinase | | 205 | R | H | | | 26 - 192 | U/L |
| 1190 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Serum Sodium | | 137 | | | | | 132 - 147 | mmol/L |
| 1191 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Serum Potassium | | 4.6 | | | | | 3.5 - 5.2 | mmol/L |
| 1192 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Serum Bicarbonate | | 24.4 | | | | | 19.3 - 29.3 | mmol/L |
| 1193 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CHEMISTRY PANEL | Serum Chloride | | 100 | | | | | 94 - 112 | mmol/L |
| 1194 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | CRYSTALS | Ur Calcium Oxalate Crystals | | Present | | | | | Ref Rng:Not present | |
| 1195 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 138 | | | | | 116 - 164 | g/L |
| 1196 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 1197 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.4 | | | | | 4.1 - 5.6 | TI/L |
| 1198 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1199 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 1200 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 9.95 | | | | | 3.8 - 10.7 | GI/L |
| 1201 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 5.30 | | | | | 1.96 - 7.23 | GI/L |
| 1202 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.84 | R | | | | 0.91 - 4.28 | GI/L |
| 1203 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.62 | | | | | 0.12 - 0.92 | GI/L |
| 1204 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.14 | | | | | 0 - 0.57 | GI/L |
| 1205 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | | 0 - 0.2 | GI/L |
| 1206 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 53.3 | | | | | 40.5 - 75 | % |
| 1207 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 38.6 | | | | | 15.4 - 48.5 | % |
| 1208 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.2 | | | | | 2.6 - 10.1 | % |
| 1209 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.4 | | | | | 0 - 6.8 | % |
| 1210 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 1211 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 486 | R | H | | | 140 - 400 | GI/L |
| 1212 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 118.97 | R | H | | | 1.9 - 23 | uIU/mL |
| 1213 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1214 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.32 | | | | | 1.03 - 1.53 | mmol/L |
| 1215 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | LIPID PANEL | Triglycerides (GPO) | | 2.60 | R | H | | | 0.51 - 2.42 | mmol/L |
| 1216 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | LIPID PANEL | Cholesterol (High Performance) | | 5.47 | | | | | 4.01 - 6.85 | mmol/L |
| 1217 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.96 | | | | | 0 - 3.34 | mmol/L |
| 1218 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | RETICULOCYTES | Reticulocyte Count % | | 1.4 | | | | | 0.6 - 2.5 | % |
| 1219 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Specific Gravity | | 1.033 | R | | | | 1 - 1.04 | |
| 1220 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1221 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Protein | | +2 | R | H SF | | | Ref Rng:Negative | |
| 1222 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1223 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Ketones | | Trace | R | H | | | Ref Rng:Negative | |
| 1224 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1225 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1226 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1227 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1228 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +3 | R | H SF | | | Ref Rng:Negative | |
| 1229 | CZ100040006 | | | 48 | years | Female | Part 1 DB Baseline | | Feb 27, 2026 11:35 AM | 6227547332 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1230 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 9.0 | R | H | | | 0 - 5 | mg/L |
| 1231 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CELLULAR ELEMENTS | Ur WBC/HPF | | 6 | | | | | 0 - 12 | /HPF |
| 1232 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CELLULAR ELEMENTS | Ur Squamous Epithelial Cells | | 38 | | | | | 0 - 3 | /HPF |
| 1233 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Total Bilirubin | | 11 | | | | | 3 - 21 | umol/L |
| 1234 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.5 | | | | | 0 - 6.2 | umol/L |
| 1235 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Alkaline Phosphatase | | 65 | | | | | 35 - 104 | U/L |
| 1236 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | ALT (SGPT) | | 16 | | | | | 4 - 43 | U/L |
| 1237 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | AST (SGOT) | | 17 | | | | | 8 - 40 | U/L |
| 1238 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | GGT | | 16 | | | | | 5 - 50 | U/L |
| 1239 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | LDH | | 183 | | | | | 53 - 234 | U/L |
| 1240 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Urea Nitrogen | | 4.2 | | | | | 1.4 - 8.6 | mmol/L |
| 1241 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 58 | | | | | 31 - 101 | umol/L |
| 1242 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Glucose Fasting | | 5.0 | | | | | 3.9 - 5.6 | mmol/L |
| 1243 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Serum Uric Acid | | 133 | R | L | | | 149 - 446 | umol/L |
| 1244 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.43 | | | | | 2.07 - 2.64 | mmol/L |
| 1245 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Phosphorus | | 0.91 | | | | | 0.71 - 1.65 | mmol/L |
| 1246 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Total Protein | | 63 | | | | | 60 - 80 | g/L |
| 1247 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Albumin-BCG | | 42 | | | | | 33 - 49 | g/L |
| 1248 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Creatine Kinase | | 87 | | | | | 26 - 192 | U/L |
| 1249 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 135 - 145 | mmol/L |
| 1250 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Serum Potassium | | 4.2 | | | | | 3.5 - 5.2 | mmol/L |
| 1251 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Serum Bicarbonate | | 22.0 | | | | | 19.3 - 29.3 | mmol/L |
| 1252 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CHEMISTRY PANEL | Serum Chloride | | 106 | | | | | 94 - 112 | mmol/L |
| 1253 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.29 | | | | | 1.25 - 1.92 | mL/sec |
| 1254 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 58 | | | | | 31 - 101 | umol/L |
| 1255 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 58.2 | | | | | kg | |
| 1256 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 1257 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1258 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 1259 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1260 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1261 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1262 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1263 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | | | | | | |
| 1264 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | GFR | EGFR by MDRD | | 90 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 1265 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 148 | | | | | 115 - 158 | g/L |
| 1266 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.45 | | | | | 0.34 - 0.48 | |
| 1267 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.6 | | | | | 3.9 - 5.5 | TI/L |
| 1268 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1269 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 99 | | | | | 80 - 100 | fL |
| 1270 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.46 | | | | | 3.8 - 10.7 | GI/L |
| 1271 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.63 | | | | | 1.96 - 7.23 | GI/L |
| 1272 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.19 | | | | | 0.8 - 3 | GI/L |
| 1273 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.49 | | | | | 0.12 - 0.92 | GI/L |
| 1274 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.12 | | | | | 0 - 0.57 | GI/L |
| 1275 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.03 | | | | | 0 - 0.2 | GI/L |
| 1276 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 66.4 | | | | | 40.5 - 75 | % |
| 1277 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 21.7 | | | | | 15.4 - 48.5 | % |
| 1278 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 9.0 | | | | | 2.6 - 10.1 | % |
| 1279 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.2 | | | | | 0 - 6.8 | % |
| 1280 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 1281 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 247 | | | | | 130 - 394 | GI/L |
| 1282 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.4 | | | | | <6.5 % | |
| 1283 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 3.23 | | | | | 1.9 - 23 | uIU/mL |
| 1284 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1285 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 1286 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.28 | | | | | 1.03 - 1.53 | mmol/L |
| 1287 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | LIPID PANEL | Triglycerides (GPO) | | 0.70 | | | | | 0.63 - 2.71 | mmol/L |
| 1288 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | LIPID PANEL | Cholesterol (High Performance) | | 4.86 | | | | | 4.86 - 8.28 | mmol/L |
| 1289 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.26 | | | | | 0 - 3.34 | mmol/L |
| 1290 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 1291 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | MISCELLANEOUS ELEMENTS | Ur Mucous | | Present | | | | | Ref Rng:Not present | |
| 1292 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | No | | | | | | |
| 1293 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | RETICULOCYTES | Reticulocyte Count % | | 1.2 | | | | | 0.6 - 2.5 | % |
| 1294 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | TSH | TSH 3rd IS-QT | | 1.723 | | | | | 0.45 - 5.33 | mIU/L |
| 1295 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Specific Gravity | | 1.023 | | | | | 1.01 - 1.03 | |
| 1296 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1297 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Protein | | Trace | R | H | | | Ref Rng:Negative | |
| 1298 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Glucose | | Trace | R | H | | | Ref Rng:Normal | |
| 1299 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1300 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1301 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1302 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1303 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1304 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1305 | CZ100040007 | | | 66 | years | Female | Part 1 Screening | | Feb 27, 2026 8:00 AM | 6227547329 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1306 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 3.1 | | | | | 0 - 5 | mg/L |
| 1307 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Total Bilirubin | | 4 | | | | | 3 - 21 | umol/L |
| 1308 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.6 | | | | | 0 - 6.2 | umol/L |
| 1309 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Alkaline Phosphatase | | 89 | | | | | 35 - 104 | U/L |
| 1310 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | ALT (SGPT) | | 14 | | | | | 4 - 43 | U/L |
| 1311 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | AST (SGOT) | | 15 | | | | | 8 - 40 | U/L |
| 1312 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | GGT | | 17 | | | | | 5 - 50 | U/L |
| 1313 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | LDH | | 151 | | | | | 53 - 234 | U/L |
| 1314 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Urea Nitrogen | | 6.7 | | | | | 1.4 - 10.4 | mmol/L |
| 1315 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 70 | | | | | 31 - 110 | umol/L |
| 1316 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Glucose Fasting | | 5.7 | R | H | | | 3.9 - 5.6 | mmol/L |
| 1317 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Serum Uric Acid | | 312 | | | | | 149 - 446 | umol/L |
| 1318 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.45 | | | | | 2.07 - 2.64 | mmol/L |
| 1319 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Phosphorus | | 1.48 | | | | | 0.71 - 1.65 | mmol/L |
| 1320 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Total Protein | | 77 | | | | | 60 - 80 | g/L |
| 1321 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 46 | g/L |
| 1322 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Creatine Kinase | | 66 | | | | | 26 - 192 | U/L |
| 1323 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 135 - 145 | mmol/L |
| 1324 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 1325 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.8 | | | | | 19.3 - 29.3 | mmol/L |
| 1326 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 1327 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 161 | R | H | | | 115 - 158 | g/L |
| 1328 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.48 | | | | | 0.34 - 0.48 | |
| 1329 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.3 | | | | | 3.9 - 5.5 | TI/L |
| 1330 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1331 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 91 | | | | | 80 - 100 | fL |
| 1332 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 9.57 | | | | | 3.8 - 10.7 | GI/L |
| 1333 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 5.16 | | | | | 1.96 - 7.23 | GI/L |
| 1334 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.42 | R | H | | | 0.8 - 3 | GI/L |
| 1335 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.76 | | | | | 0.12 - 0.92 | GI/L |
| 1336 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 1337 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.06 | | | | | 0 - 0.2 | GI/L |
| 1338 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 54.0 | | | | | 40.5 - 75 | % |
| 1339 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 35.8 | | | | | 15.4 - 48.5 | % |
| 1340 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 8.0 | | | | | 2.6 - 10.1 | % |
| 1341 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.6 | | | | | 0 - 6.8 | % |
| 1342 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 1343 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 300 | | | | | 130 - 394 | GI/L |
| 1344 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 7.83 | | | | | 1.9 - 23 | uIU/mL |
| 1345 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1346 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.33 | | | | | 1.03 - 1.53 | mmol/L |
| 1347 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | LIPID PANEL | Triglycerides (GPO) | | 2.03 | | | | | 0.63 - 2.71 | mmol/L |
| 1348 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | LIPID PANEL | Cholesterol (High Performance) | | 6.94 | | | | | 5.35 - 9.1 | mmol/L |
| 1349 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.68 | | H | | | 0 - 3.34 | mmol/L |
| 1350 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | RETICULOCYTES | Reticulocyte Count % | | 1.8 | | | | | 0.6 - 2.5 | % |
| 1351 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Specific Gravity | | 1.009 | | | | | 1.01 - 1.03 | |
| 1352 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1353 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1354 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1355 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1356 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1357 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1358 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1359 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1360 | CZ100040005 | | | 72 | years | Female | Part 1 DB Baseline | | Feb 20, 2026 10:45 AM | 6227541252 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1361 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.1 | | | | | 0 - 5 | mg/L |
| 1362 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CELLULAR ELEMENTS | Ur WBC/HPF | | 5 | | | | | 0 - 12 | /HPF |
| 1363 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CELLULAR ELEMENTS | Ur Transitional Epi Cells | | 1 | | | | | 0 /HPF | |
| 1364 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Total Bilirubin | | 11 | | | | | 3 - 21 | umol/L |
| 1365 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.3 | | | | | 0 - 6.2 | umol/L |
| 1366 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Alkaline Phosphatase | | 79 | | | | | 35 - 104 | U/L |
| 1367 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | ALT (SGPT) | | 21 | | | | | 4 - 43 | U/L |
| 1368 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | AST (SGOT) | | 21 | | | | | 8 - 40 | U/L |
| 1369 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | GGT | | 17 | | | | | 4 - 49 | U/L |
| 1370 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | LDH | | 205 | | | | | 53 - 234 | U/L |
| 1371 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Urea Nitrogen | | 3.7 | | | | | 1.4 - 8.6 | mmol/L |
| 1372 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 73 | | | | | 31 - 101 | umol/L |
| 1373 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 1374 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Serum Uric Acid | | 239 | | | | | 149 - 446 | umol/L |
| 1375 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.44 | | | | | 2.07 - 2.64 | mmol/L |
| 1376 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Phosphorus | | 1.25 | | | | | 0.71 - 1.65 | mmol/L |
| 1377 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Total Protein | | 70 | | | | | 61 - 84 | g/L |
| 1378 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 1379 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Creatine Kinase | | 100 | | | | | 26 - 192 | U/L |
| 1380 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 132 - 147 | mmol/L |
| 1381 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Serum Potassium | | 4.6 | | | | | 3.5 - 5.2 | mmol/L |
| 1382 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.3 | | | | | 19.3 - 29.3 | mmol/L |
| 1383 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 1384 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 140 | | | | | 116 - 164 | g/L |
| 1385 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 1386 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.6 | | | | | 4.1 - 5.6 | TI/L |
| 1387 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1388 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 93 | | | | | 79 - 98 | fL |
| 1389 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.66 | | | | | 3.8 - 10.7 | GI/L |
| 1390 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.75 | | | | | 1.96 - 7.23 | GI/L |
| 1391 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.38 | | | | | 0.91 - 4.28 | GI/L |
| 1392 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.39 | | | | | 0.12 - 0.92 | GI/L |
| 1393 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.12 | | | | | 0 - 0.57 | GI/L |
| 1394 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.02 | | | | | 0 - 0.2 | GI/L |
| 1395 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.9 | | | | | 40.5 - 75 | % |
| 1396 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 29.6 | | | | | 15.4 - 48.5 | % |
| 1397 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 8.4 | | | | | 2.6 - 10.1 | % |
| 1398 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.6 | | | | | 0 - 6.8 | % |
| 1399 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 1400 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 312 | | | | | 140 - 400 | GI/L |
| 1401 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 2.82 | | | | | 1.9 - 23 | uIU/mL |
| 1402 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1403 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.68 | | H | | | 1.03 - 1.53 | mmol/L |
| 1404 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | LIPID PANEL | Triglycerides (GPO) | | 0.71 | | | | | 0.59 - 2.96 | mmol/L |
| 1405 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | LIPID PANEL | Cholesterol (High Performance) | | 5.23 | | | | | 4.42 - 7.53 | mmol/L |
| 1406 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.22 | | | | | 0 - 3.34 | mmol/L |
| 1407 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | RETICULOCYTES | Reticulocyte Count % | | 1.3 | | | | | 0.6 - 2.5 | % |
| 1408 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Specific Gravity | | 1.023 | | | | | 1 - 1.04 | |
| 1409 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur pH | | 6.5 | | | | | 5 - 8 | |
| 1410 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Protein | | Trace | | H | | | Ref Rng:Negative | |
| 1411 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1412 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1413 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1414 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1415 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1416 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1417 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Trace | | H | | | Ref Rng:Negative | |
| 1418 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Day 29 | | Feb 13, 2026 8:45 AM | 6227541259 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1419 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.4 | | | | | 0 - 5 | mg/L |
| 1420 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CELLULAR ELEMENTS | Ur WBC/HPF | | >150 | | HT | | | 0 - 12 | /HPF |
| 1421 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Total Bilirubin | | 4 | | | | | 3 - 21 | umol/L |
| 1422 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.5 | | | | | 0 - 6.2 | umol/L |
| 1423 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Alkaline Phosphatase | | 76 | | | | | 35 - 104 | U/L |
| 1424 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | ALT (SGPT) | | 16 | | | | | 4 - 43 | U/L |
| 1425 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | AST (SGOT) | | 20 | | | | | 8 - 40 | U/L |
| 1426 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | GGT | | 25 | | | | | 4 - 49 | U/L |
| 1427 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | LDH | | 130 | | | | | 53 - 234 | U/L |
| 1428 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Urea Nitrogen | | 5.1 | | | | | 1.4 - 8.6 | mmol/L |
| 1429 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 53 | | | | | 31 - 101 | umol/L |
| 1430 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 1431 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Serum Uric Acid | | 357 | | | | | 125 - 428 | umol/L |
| 1432 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.43 | | | | | 2.07 - 2.64 | mmol/L |
| 1433 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Phosphorus | | 1.26 | | | | | 0.71 - 1.65 | mmol/L |
| 1434 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Total Protein | | 69 | | | | | 61 - 84 | g/L |
| 1435 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Albumin-BCG | | 43 | | | | | 33 - 49 | g/L |
| 1436 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Creatine Kinase | | 154 | | | | | 26 - 192 | U/L |
| 1437 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Serum Sodium | | 138 | | | | | 132 - 147 | mmol/L |
| 1438 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Serum Potassium | | 4.5 | | | | | 3.5 - 5.2 | mmol/L |
| 1439 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.0 | | | | | 19.3 - 29.3 | mmol/L |
| 1440 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CHEMISTRY PANEL | Serum Chloride | | 103 | | | | | 94 - 112 | mmol/L |
| 1441 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 2.63 | | H | | | 1.25 - 1.92 | mL/sec |
| 1442 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 53 | | | | | 31 - 101 | umol/L |
| 1443 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 87.2 | | | | | kg | |
| 1444 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 1445 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1446 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 1447 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1448 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1449 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1450 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1451 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | | | | | | |
| 1452 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | GFR | EGFR by MDRD | | 107 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 1453 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 142 | | | | | 116 - 164 | g/L |
| 1454 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.42 | | | | | 0.34 - 0.48 | |
| 1455 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.5 | | | | | 4.1 - 5.6 | TI/L |
| 1456 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1457 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 92 | | | | | 79 - 98 | fL |
| 1458 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 11.22 | R | H | | | 3.8 - 10.7 | GI/L |
| 1459 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.93 | | | | | 1.96 - 7.23 | GI/L |
| 1460 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.51 | | | | | 0.91 - 4.28 | GI/L |
| 1461 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.50 | | | | | 0.12 - 0.92 | GI/L |
| 1462 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.22 | | | | | 0 - 0.57 | GI/L |
| 1463 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | | 0 - 0.2 | GI/L |
| 1464 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 61.8 | | | | | 40.5 - 75 | % |
| 1465 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 31.3 | | | | | 15.4 - 48.5 | % |
| 1466 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 4.4 | | | | | 2.6 - 10.1 | % |
| 1467 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.0 | | | | | 0 - 6.8 | % |
| 1468 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 1469 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 509 | R | H | | | 140 - 400 | GI/L |
| 1470 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 6.4 | | | | | <6.5 % | |
| 1471 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 39.05 | | H | | | 1.9 - 23 | uIU/mL |
| 1472 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1473 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 1474 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.21 | | | | | 1.03 - 1.53 | mmol/L |
| 1475 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | LIPID PANEL | Triglycerides (GPO) | | 3.23 | | H | | | 0.51 - 2.42 | mmol/L |
| 1476 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | LIPID PANEL | Cholesterol (High Performance) | | 5.80 | | | | | 4.01 - 6.85 | mmol/L |
| 1477 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.11 | | | | | 0 - 3.34 | mmol/L |
| 1478 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | No | | | | | | |
| 1479 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | RETICULOCYTES | Reticulocyte Count % | | 1.9 | | | | | 0.6 - 2.5 | % |
| 1480 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | SERUM BETA HCG | B-hCG, Qualitative | | Negative | | | | | Ref Rng: Negative | |
| 1481 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | SERUM BETA HCG | B-hCG, Quantitative | | <0.6 | | | | | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |
| 1482 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | TSH | TSH 3rd IS-QT | | 2.280 | | | | | 0.45 - 5.33 | mIU/L |
| 1483 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Specific Gravity | | 1.023 | | | | | 1 - 1.04 | |
| 1484 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1485 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Protein | | Trace | | H | | | Ref Rng:Negative | |
| 1486 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1487 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1488 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1489 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1490 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1491 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1492 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +3 | | H SF | | | Ref Rng:Negative | |
| 1493 | CZ100040006 | | | 48 | years | Female | Part 1 Screening | | Jan 30, 2026 11:40 AM | 6227547330 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1494 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 7.3 | | H | | | 0 - 5 | mg/L |
| 1495 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CELLULAR ELEMENTS | Ur WBC/HPF | | 32 | | H | | | 0 - 12 | /HPF |
| 1496 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Total Bilirubin | | 13 | | | | | 3 - 21 | umol/L |
| 1497 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 4.9 | | | | | 0 - 6.2 | umol/L |
| 1498 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Alkaline Phosphatase | | 94 | | | | | 35 - 104 | U/L |
| 1499 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | ALT (SGPT) | | 55 | | H | | | 4 - 43 | U/L |
| 1500 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | AST (SGOT) | | 30 | | | | | 8 - 40 | U/L |
| 1501 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | GGT | | 27 | | | | | 4 - 49 | U/L |
| 1502 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | LDH | | 175 | | | | | 53 - 234 | U/L |
| 1503 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Urea Nitrogen | | 4.6 | | | | | 1.4 - 8.6 | mmol/L |
| 1504 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 75 | | | | | 31 - 101 | umol/L |
| 1505 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Glucose Fasting | | 7.2 | | H | | | 3.9 - 5.6 | mmol/L |
| 1506 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Serum Uric Acid | | 263 | | | | | 149 - 446 | umol/L |
| 1507 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.41 | | | | | 2.07 - 2.64 | mmol/L |
| 1508 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Phosphorus | | 0.95 | | | | | 0.71 - 1.65 | mmol/L |
| 1509 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Total Protein | | 69 | | | | | 61 - 84 | g/L |
| 1510 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Albumin-BCG | | 47 | | | | | 33 - 49 | g/L |
| 1511 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Creatine Kinase | | 38 | | | | | 26 - 192 | U/L |
| 1512 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 1513 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 1514 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.0 | | | | | 19.3 - 29.3 | mmol/L |
| 1515 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | CHEMISTRY PANEL | Serum Chloride | | 101 | | | | | 94 - 112 | mmol/L |
| 1516 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 159 | | | | | 116 - 164 | g/L |
| 1517 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.47 | | | | | 0.34 - 0.48 | |
| 1518 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.2 | | | | | 4.1 - 5.6 | TI/L |
| 1519 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1520 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 90 | | | | | 79 - 98 | fL |
| 1521 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 7.29 | | | | | 3.8 - 10.7 | GI/L |
| 1522 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.53 | | | | | 1.96 - 7.23 | GI/L |
| 1523 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.07 | | | | | 0.91 - 4.28 | GI/L |
| 1524 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.45 | | | | | 0.12 - 0.92 | GI/L |
| 1525 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 1526 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.08 | | | | | 0 - 0.2 | GI/L |
| 1527 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 62.2 | | | | | 40.5 - 75 | % |
| 1528 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 28.5 | | | | | 15.4 - 48.5 | % |
| 1529 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.2 | | | | | 2.6 - 10.1 | % |
| 1530 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.1 | | | | | 0 - 6.8 | % |
| 1531 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.1 | | | | | 0 - 2 | % |
| 1532 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 296 | | | | | 140 - 400 | GI/L |
| 1533 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 6.4 | | | | | <6.5 % | |
| 1534 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 33.25 | | H | | | 1.9 - 23 | uIU/mL |
| 1535 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1536 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.02 | | L | | | 1.03 - 1.53 | mmol/L |
| 1537 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | LIPID PANEL | Triglycerides (GPO) | | 1.15 | | | | | 0.59 - 2.96 | mmol/L |
| 1538 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | LIPID PANEL | Cholesterol (High Performance) | | 2.80 | | L | | | 4.42 - 7.53 | mmol/L |
| 1539 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.25 | | | | | 0 - 3.34 | mmol/L |
| 1540 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 1541 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | RETICULOCYTES | Reticulocyte Count % | | 1.6 | | | | | 0.6 - 2.5 | % |
| 1542 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | TSH | TSH 3rd IS-QT | | 0.595 | | | | | 0.45 - 5.33 | mIU/L |
| 1543 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Specific Gravity | | 1.015 | | | | | 1 - 1.04 | |
| 1544 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 1545 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1546 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1547 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1548 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1549 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1550 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1551 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1552 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +3 | | H SF | | | Ref Rng:Negative | |
| 1553 | CZ100040003 | | | 55 | years | Female | End of Phase/Treatment | | Jan 30, 2026 9:30 AM | 6227178909 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1554 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.8 | | | | | 0 - 5 | mg/L |
| 1555 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CELLULAR ELEMENTS | Ur RBC/HPF | | 1 | | | | | 0 - 8 | /HPF |
| 1556 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CELLULAR ELEMENTS | Ur WBC/HPF | | 2 | | | | | 0 - 12 | /HPF |
| 1557 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Total Bilirubin | | 6 | | | | | 3 - 21 | umol/L |
| 1558 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.5 | | | | | 0 - 6.2 | umol/L |
| 1559 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Alkaline Phosphatase | | 87 | | | | | 35 - 104 | U/L |
| 1560 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | ALT (SGPT) | | 14 | | | | | 4 - 43 | U/L |
| 1561 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | AST (SGOT) | | 16 | | | | | 8 - 40 | U/L |
| 1562 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | GGT | | 15 | | | | | 5 - 50 | U/L |
| 1563 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | LDH | | 150 | | | | | 53 - 234 | U/L |
| 1564 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Urea Nitrogen | | 5.0 | | | | | 1.4 - 10.4 | mmol/L |
| 1565 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 63 | | | | | 31 - 110 | umol/L |
| 1566 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Glucose Fasting | | 7.0 | | H | | | 3.9 - 5.6 | mmol/L |
| 1567 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Serum Uric Acid | | 320 | | | | | 149 - 446 | umol/L |
| 1568 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.39 | | | | | 2.07 - 2.64 | mmol/L |
| 1569 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Phosphorus | | 1.31 | | | | | 0.71 - 1.65 | mmol/L |
| 1570 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Total Protein | | 78 | | | | | 60 - 80 | g/L |
| 1571 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 46 | g/L |
| 1572 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Creatine Kinase | | 87 | | | | | 26 - 192 | U/L |
| 1573 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 135 - 145 | mmol/L |
| 1574 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Serum Potassium | | 4.4 | | | | | 3.5 - 5.2 | mmol/L |
| 1575 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.1 | | | | | 19.3 - 29.3 | mmol/L |
| 1576 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 1577 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.29 | | | | | 1.25 - 1.92 | mL/sec |
| 1578 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 63 | | | | | 31 - 110 | umol/L |
| 1579 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 68.5 | | | | | kg | |
| 1580 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | CRYSTALS | Ur Calcium Oxalate Crystals | | Present | | | | | Ref Rng:Not present | |
| 1581 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 1582 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1583 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 1584 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1585 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1586 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 1587 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 1588 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | | | | | | |
| 1589 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | FSH | Follicle Stimulating Hormone | | 78.10 | | | | | Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L | |
| 1590 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | GFR | EGFR by MDRD | | 81 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 1591 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 165 | | H | | | 115 - 158 | g/L |
| 1592 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.48 | | | | | 0.34 - 0.48 | |
| 1593 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.3 | | | | | 3.9 - 5.5 | TI/L |
| 1594 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1595 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 90 | | | | | 80 - 100 | fL |
| 1596 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 10.07 | | | | | 3.8 - 10.7 | GI/L |
| 1597 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.15 | | | | | 1.96 - 7.23 | GI/L |
| 1598 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.08 | | H | | | 0.8 - 3 | GI/L |
| 1599 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.65 | | | | | 0.12 - 0.92 | GI/L |
| 1600 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.14 | | | | | 0 - 0.57 | GI/L |
| 1601 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.05 | | | | | 0 - 0.2 | GI/L |
| 1602 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 61.0 | | | | | 40.5 - 75 | % |
| 1603 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 30.6 | | | | | 15.4 - 48.5 | % |
| 1604 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.5 | | | | | 2.6 - 10.1 | % |
| 1605 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.4 | | | | | 0 - 6.8 | % |
| 1606 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 1607 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 269 | | | | | 130 - 394 | GI/L |
| 1608 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.9 | | | | | <6.5 % | |
| 1609 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 47.53 | | H | | | 1.9 - 23 | uIU/mL |
| 1610 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1611 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 1612 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.28 | | | | | 1.03 - 1.53 | mmol/L |
| 1613 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | LIPID PANEL | Triglycerides (GPO) | | 1.84 | | | | | 0.63 - 2.71 | mmol/L |
| 1614 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | LIPID PANEL | Cholesterol (High Performance) | | 6.82 | | | | | 5.35 - 9.1 | mmol/L |
| 1615 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.70 | | H | | | 0 - 3.34 | mmol/L |
| 1616 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 1617 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | Yes | | | | | | |
| 1618 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | RETICULOCYTES | Reticulocyte Count % | | 1.4 | | | | | 0.6 - 2.5 | % |
| 1619 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | TSH | TSH 3rd IS-QT | | 1.806 | | | | | 0.45 - 5.33 | mIU/L |
| 1620 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Specific Gravity | | 1.025 | | | | | 1.01 - 1.03 | |
| 1621 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1622 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Protein | | Trace | | H | | | Ref Rng:Negative | |
| 1623 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1624 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1625 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1626 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1627 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Blood | | Trace | | | | | Ref Rng:$Negative-Trace | |
| 1628 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1629 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1630 | CZ100040005 | | | 72 | years | Female | Part 1 Screening | | Jan 27, 2026 9:00 AM | 6227541249 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1631 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.0 | | | | | 0 - 5 | mg/L |
| 1632 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CELLULAR ELEMENTS | Ur WBC/HPF | | 27 | | H | | | 0 - 12 | /HPF |
| 1633 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Total Bilirubin | | 13 | | | | | 3 - 21 | umol/L |
| 1634 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 4.7 | | | | | 0 - 6.2 | umol/L |
| 1635 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Alkaline Phosphatase | | 84 | | | | | 35 - 104 | U/L |
| 1636 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | ALT (SGPT) | | 53 | | H | | | 4 - 43 | U/L |
| 1637 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | AST (SGOT) | | 26 | | | | | 8 - 40 | U/L |
| 1638 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | GGT | | 26 | | | | | 4 - 49 | U/L |
| 1639 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | LDH | | 172 | | | | | 53 - 234 | U/L |
| 1640 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Urea Nitrogen | | 5.2 | | | | | 1.4 - 8.6 | mmol/L |
| 1641 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 75 | | | | | 31 - 101 | umol/L |
| 1642 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Glucose Fasting | | 6.8 | | H | | | 3.9 - 5.6 | mmol/L |
| 1643 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Serum Uric Acid | | 279 | | | | | 149 - 446 | umol/L |
| 1644 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.39 | | | | | 2.07 - 2.64 | mmol/L |
| 1645 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Phosphorus | | 1.21 | | | | | 0.71 - 1.65 | mmol/L |
| 1646 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Total Protein | | 66 | | | | | 61 - 84 | g/L |
| 1647 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 49 | g/L |
| 1648 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Creatine Kinase | | 45 | | | | | 26 - 192 | U/L |
| 1649 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 132 - 147 | mmol/L |
| 1650 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 1651 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.1 | | | | | 19.3 - 29.3 | mmol/L |
| 1652 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 1653 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | CRYSTALS | Ur Calcium Oxalate Crystals | | Present | | | | | Ref Rng:Not present | |
| 1654 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 153 | | | | | 116 - 164 | g/L |
| 1655 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.46 | | | | | 0.34 - 0.48 | |
| 1656 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.0 | | | | | 4.1 - 5.6 | TI/L |
| 1657 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1658 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 92 | | | | | 79 - 98 | fL |
| 1659 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 8.45 | | | | | 3.8 - 10.7 | GI/L |
| 1660 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.94 | | | | | 1.96 - 7.23 | GI/L |
| 1661 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.68 | | | | | 0.91 - 4.28 | GI/L |
| 1662 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.51 | | | | | 0.12 - 0.92 | GI/L |
| 1663 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.24 | | | | | 0 - 0.57 | GI/L |
| 1664 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.09 | | | | | 0 - 0.2 | GI/L |
| 1665 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.4 | | | | | 40.5 - 75 | % |
| 1666 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 31.7 | | | | | 15.4 - 48.5 | % |
| 1667 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.0 | | | | | 2.6 - 10.1 | % |
| 1668 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.9 | | | | | 0 - 6.8 | % |
| 1669 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.0 | | | | | 0 - 2 | % |
| 1670 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 302 | | | | | 140 - 400 | GI/L |
| 1671 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 13.07 | | | | | 1.9 - 23 | uIU/mL |
| 1672 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1673 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | LIPID PANEL | Direct HDL-C 4th Generation | | 0.98 | | L | | | 1.03 - 1.53 | mmol/L |
| 1674 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | LIPID PANEL | Triglycerides (GPO) | | 0.95 | | | | | 0.59 - 2.96 | mmol/L |
| 1675 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | LIPID PANEL | Cholesterol (High Performance) | | 2.57 | | L | | Result verified by repeat analysis | 4.42 - 7.53 | mmol/L |
| 1676 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.15 | | | | | 0 - 3.34 | mmol/L |
| 1677 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | RETICULOCYTES | Reticulocyte Count % | | 2.1 | | | | | 0.6 - 2.5 | % |
| 1678 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Specific Gravity | | 1.023 | | | | | 1 - 1.04 | |
| 1679 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1680 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1681 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1682 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1683 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1684 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1685 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1686 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1687 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +3 | | H SF | | | Ref Rng:Negative | |
| 1688 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Day 29 | | Jan 16, 2026 10:40 AM | 6227541260 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1689 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 0.9 | | | | | 0 - 5 | mg/L |
| 1690 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CELLULAR ELEMENTS | Ur WBC/HPF | | 5 | | | | | 0 - 12 | /HPF |
| 1691 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CELLULAR ELEMENTS | Ur Transitional Epi Cells | | 1 | | | | | 0 /HPF | |
| 1692 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Total Bilirubin | | 8 | | | | | 3 - 21 | umol/L |
| 1693 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.9 | | | | | 0 - 6.2 | umol/L |
| 1694 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Alkaline Phosphatase | | 71 | | | | | 35 - 104 | U/L |
| 1695 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | ALT (SGPT) | | 17 | | | | | 4 - 43 | U/L |
| 1696 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | AST (SGOT) | | 20 | | | | | 8 - 40 | U/L |
| 1697 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | GGT | | 18 | | | | | 4 - 49 | U/L |
| 1698 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | LDH | | 203 | | | | | 53 - 234 | U/L |
| 1699 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Urea Nitrogen | | 3.2 | | | | | 1.4 - 8.6 | mmol/L |
| 1700 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 70 | | | | | 31 - 101 | umol/L |
| 1701 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Glucose Fasting | | 5.1 | | | | | 3.9 - 5.6 | mmol/L |
| 1702 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Serum Uric Acid | | 221 | | | | | 149 - 446 | umol/L |
| 1703 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.34 | | | | | 2.07 - 2.64 | mmol/L |
| 1704 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Phosphorus | | 1.12 | | | | | 0.71 - 1.65 | mmol/L |
| 1705 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Total Protein | | 64 | | | | | 61 - 84 | g/L |
| 1706 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Albumin-BCG | | 44 | | | | | 33 - 49 | g/L |
| 1707 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Creatine Kinase | | 96 | | | | | 26 - 192 | U/L |
| 1708 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Serum Sodium | | 142 | | | | | 132 - 147 | mmol/L |
| 1709 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Serum Potassium | | 4.4 | | | | | 3.5 - 5.2 | mmol/L |
| 1710 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Serum Bicarbonate | | 27.1 | | | | | 19.3 - 29.3 | mmol/L |
| 1711 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | CHEMISTRY PANEL | Serum Chloride | | 104 | | | | | 94 - 112 | mmol/L |
| 1712 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 134 | | | | | 116 - 164 | g/L |
| 1713 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.40 | | | | | 0.34 - 0.48 | |
| 1714 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.3 | | | | | 4.1 - 5.6 | TI/L |
| 1715 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1716 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 93 | | | | | 79 - 98 | fL |
| 1717 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.16 | | | | | 3.8 - 10.7 | GI/L |
| 1718 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.30 | | | | | 1.96 - 7.23 | GI/L |
| 1719 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.50 | | | | | 0.91 - 4.28 | GI/L |
| 1720 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.23 | | | | | 0.12 - 0.92 | GI/L |
| 1721 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.13 | | | | | 0 - 0.57 | GI/L |
| 1722 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.01 | | | | | 0 - 0.2 | GI/L |
| 1723 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 55.2 | | | | | 40.5 - 75 | % |
| 1724 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 36.0 | | | | | 15.4 - 48.5 | % |
| 1725 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.5 | | | | | 2.6 - 10.1 | % |
| 1726 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 3.0 | | | | | 0 - 6.8 | % |
| 1727 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.3 | | | | | 0 - 2 | % |
| 1728 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 272 | | | | | 140 - 400 | GI/L |
| 1729 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.3 | | | | | <6.5 % | |
| 1730 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 2.94 | | | | | 1.9 - 23 | uIU/mL |
| 1731 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1732 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.49 | | | | | 1.03 - 1.53 | mmol/L |
| 1733 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | LIPID PANEL | Triglycerides (GPO) | | 0.80 | | | | | 0.59 - 2.96 | mmol/L |
| 1734 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | LIPID PANEL | Cholesterol (High Performance) | | 4.76 | | | | | 4.42 - 7.53 | mmol/L |
| 1735 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.90 | | | | | 0 - 3.34 | mmol/L |
| 1736 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | RETICULOCYTES | Reticulocyte Count % | | 1.3 | | | | | 0.6 - 2.5 | % |
| 1737 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | TSH | TSH 3rd IS-QT | | 1.175 | | | | | 0.45 - 5.33 | mIU/L |
| 1738 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Specific Gravity | | 1.016 | | | | | 1 - 1.04 | |
| 1739 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur pH | | 7.0 | | | | | 5 - 8 | |
| 1740 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1741 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1742 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1743 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1744 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1745 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1746 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1747 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +1 | | H | | | Ref Rng:Negative | |
| 1748 | CZ100040004 | | | 54 | years | Female | Part 2 OL Induction Baseline | | Jan 16, 2026 7:55 AM | 6227541257 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1749 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.8 | | | | | 0 - 5 | mg/L |
| 1750 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Total Bilirubin | | 4 | | | | Result verified by repeat analysis | 3 - 21 | umol/L |
| 1751 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.5 | | | | | 0 - 6.2 | umol/L |
| 1752 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Alkaline Phosphatase | | 78 | | | | | 35 - 104 | U/L |
| 1753 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | ALT (SGPT) | | 40 | | | | | 4 - 43 | U/L |
| 1754 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | AST (SGOT) | | 33 | | | | | 8 - 40 | U/L |
| 1755 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | GGT | | 49 | | | | | 4 - 49 | U/L |
| 1756 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | LDH | | 151 | | | | | 53 - 234 | U/L |
| 1757 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Urea Nitrogen | | 3.6 | | | | | 1.4 - 8.6 | mmol/L |
| 1758 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 68 | | | | | 31 - 101 | umol/L |
| 1759 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Glucose Fasting | | 5.0 | | | | | 3.9 - 5.6 | mmol/L |
| 1760 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Serum Uric Acid | | 300 | | | | | 125 - 428 | umol/L |
| 1761 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.31 | | | | | 2.07 - 2.64 | mmol/L |
| 1762 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Phosphorus | | 1.35 | | | | | 0.71 - 1.65 | mmol/L |
| 1763 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Total Protein | | 67 | | | | | 61 - 84 | g/L |
| 1764 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Albumin-BCG | | 43 | | | | | 33 - 49 | g/L |
| 1765 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Creatine Kinase | | 102 | | | | | 26 - 192 | U/L |
| 1766 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 1767 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Serum Potassium | | 4.5 | | | | | 3.5 - 5.2 | mmol/L |
| 1768 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.0 | | | | | 19.3 - 29.3 | mmol/L |
| 1769 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | CHEMISTRY PANEL | Serum Chloride | | 103 | | | | | 94 - 112 | mmol/L |
| 1770 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 126 | | | | | 116 - 164 | g/L |
| 1771 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.37 | | | | | 0.34 - 0.48 | |
| 1772 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 3.9 | | L | | | 4.1 - 5.6 | TI/L |
| 1773 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1774 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 1775 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 6.94 | | | | | 3.8 - 10.7 | GI/L |
| 1776 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.95 | | | | | 1.96 - 7.23 | GI/L |
| 1777 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 3.05 | | | | | 0.91 - 4.28 | GI/L |
| 1778 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.61 | | | | | 0.12 - 0.92 | GI/L |
| 1779 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.29 | | | | | 0 - 0.57 | GI/L |
| 1780 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.04 | | | | | 0 - 0.2 | GI/L |
| 1781 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 42.5 | | | | | 40.5 - 75 | % |
| 1782 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 43.9 | | | | | 15.4 - 48.5 | % |
| 1783 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 8.7 | | | | | 2.6 - 10.1 | % |
| 1784 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 4.2 | | | | | 0 - 6.8 | % |
| 1785 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 1786 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 341 | | | | | 140 - 400 | GI/L |
| 1787 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.3 | | | | | <6.5 % | |
| 1788 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 4.23 | | | | | 1.9 - 23 | uIU/mL |
| 1789 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1790 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.37 | | | | | 1.03 - 1.53 | mmol/L |
| 1791 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | LIPID PANEL | Triglycerides (GPO) | | 1.49 | | | | | 0.51 - 2.42 | mmol/L |
| 1792 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | LIPID PANEL | Cholesterol (High Performance) | | 4.70 | | | | | 4.01 - 6.85 | mmol/L |
| 1793 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.65 | | | | | 0 - 3.34 | mmol/L |
| 1794 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | RETICULOCYTES | Reticulocyte Count % | | 2.7 | | H | | | 0.6 - 2.5 | % |
| 1795 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | TSH | TSH 3rd IS-QT | | 3.282 | | | | | 0.45 - 5.33 | mIU/L |
| 1796 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Specific Gravity | | 1.009 | | | | | 1 - 1.04 | |
| 1797 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 1798 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1799 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1800 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1801 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1802 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1803 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1804 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1805 | CZ100040002 | | | 46 | years | Female | End of Phase/Treatment | | Jan 9, 2026 10:20 AM | 6227178908 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1806 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.5 | | | | | 0 - 5 | mg/L |
| 1807 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Total Bilirubin | | 7 | | | | | 3 - 21 | umol/L |
| 1808 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.2 | | | | | 0 - 6.2 | umol/L |
| 1809 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Alkaline Phosphatase | | 99 | | | | | 35 - 104 | U/L |
| 1810 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | ALT (SGPT) | | 30 | | | | | 4 - 43 | U/L |
| 1811 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | AST (SGOT) | | 30 | | | | | 8 - 40 | U/L |
| 1812 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | GGT | | 18 | | | | | 4 - 49 | U/L |
| 1813 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | LDH | | 205 | | | | | 53 - 234 | U/L |
| 1814 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Urea Nitrogen | | 4.2 | | | | | 1.4 - 8.6 | mmol/L |
| 1815 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 76 | | | | | 31 - 101 | umol/L |
| 1816 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Glucose Fasting | | 5.1 | | | | | 3.9 - 5.6 | mmol/L |
| 1817 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Serum Uric Acid | | 323 | | | | | 149 - 446 | umol/L |
| 1818 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.27 | | | | | 2.07 - 2.64 | mmol/L |
| 1819 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Phosphorus | | 1.05 | | | | | 0.71 - 1.65 | mmol/L |
| 1820 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Total Protein | | 73 | | | | | 61 - 84 | g/L |
| 1821 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Albumin-BCG | | 47 | | | | | 33 - 49 | g/L |
| 1822 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Creatine Kinase | | 161 | | | | | 26 - 192 | U/L |
| 1823 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 1824 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Serum Potassium | | 3.7 | | | | | 3.5 - 5.2 | mmol/L |
| 1825 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Serum Bicarbonate | | 24.3 | | | | | 19.3 - 29.3 | mmol/L |
| 1826 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | CHEMISTRY PANEL | Serum Chloride | | 100 | | | | | 94 - 112 | mmol/L |
| 1827 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 144 | | | | | 116 - 164 | g/L |
| 1828 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.41 | | | | | 0.34 - 0.48 | |
| 1829 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.8 | | | | | 4.1 - 5.6 | TI/L |
| 1830 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | Normocytic | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1831 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 86 | | | | | 79 - 98 | fL |
| 1832 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.41 | | | | | 3.8 - 10.7 | GI/L |
| 1833 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.46 | | | | | 1.96 - 7.23 | GI/L |
| 1834 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.53 | | | | | 0.91 - 4.28 | GI/L |
| 1835 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.25 | | | | | 0.12 - 0.92 | GI/L |
| 1836 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 1837 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.03 | | | | | 0 - 0.2 | GI/L |
| 1838 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 55.7 | | | | | 40.5 - 75 | % |
| 1839 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 34.8 | | | | | 15.4 - 48.5 | % |
| 1840 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.6 | | | | | 2.6 - 10.1 | % |
| 1841 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 3.3 | | | | | 0 - 6.8 | % |
| 1842 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 1843 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | | | | Test cancelled: Platelet clumps present | | | |
| 1844 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 5.7 | | | | | <6.5 % | |
| 1845 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 8.57 | | | | | 1.9 - 23 | uIU/mL |
| 1846 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1847 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.14 | | | | | 1.03 - 1.53 | mmol/L |
| 1848 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | LIPID PANEL | Triglycerides (GPO) | | 1.23 | | | | | 0.59 - 2.96 | mmol/L |
| 1849 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | LIPID PANEL | Cholesterol (High Performance) | | 6.67 | | | | | 4.42 - 7.53 | mmol/L |
| 1850 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.97 | | H | | | 0 - 3.34 | mmol/L |
| 1851 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | RETICULOCYTES | Reticulocyte Count % | | 1.5 | | | | | 0.6 - 2.5 | % |
| 1852 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | TSH | TSH 3rd IS-QT | | 2.238 | | | | | 0.45 - 5.33 | mIU/L |
| 1853 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Specific Gravity | | 1.019 | | | | | 1 - 1.04 | |
| 1854 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 1855 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1856 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1857 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1858 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1859 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1860 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1861 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1862 | CZ100040001 | | | 56 | years | Female | End of Phase/Treatment | | Jan 9, 2026 9:10 AM | 6227178912 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 1863 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 3.3 | | | | | 0 - 5 | mg/L |
| 1864 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CELLULAR ELEMENTS | Ur WBC/HPF | | 9 | | | | | 0 - 12 | /HPF |
| 1865 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Total Bilirubin | | 14 | | | | | 3 - 21 | umol/L |
| 1866 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 4.8 | | | | | 0 - 6.2 | umol/L |
| 1867 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Alkaline Phosphatase | | 94 | | | | | 35 - 104 | U/L |
| 1868 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | ALT (SGPT) | | 50 | | H | | | 4 - 43 | U/L |
| 1869 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | AST (SGOT) | | 27 | | | | | 8 - 40 | U/L |
| 1870 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | GGT | | 24 | | | | | 4 - 49 | U/L |
| 1871 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | LDH | | 167 | | | | | 53 - 234 | U/L |
| 1872 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Urea Nitrogen | | 4.6 | | | | | 1.4 - 8.6 | mmol/L |
| 1873 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 72 | | | | | 31 - 101 | umol/L |
| 1874 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Glucose Fasting | | 6.3 | | H | | | 3.9 - 5.6 | mmol/L |
| 1875 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Serum Uric Acid | | 274 | | | | | 149 - 446 | umol/L |
| 1876 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.43 | | | | | 2.07 - 2.64 | mmol/L |
| 1877 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Phosphorus | | 1.21 | | | | | 0.71 - 1.65 | mmol/L |
| 1878 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Total Protein | | 67 | | | | | 61 - 84 | g/L |
| 1879 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Albumin-BCG | | 45 | | | | | 33 - 49 | g/L |
| 1880 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Creatine Kinase | | 45 | | | | | 26 - 192 | U/L |
| 1881 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 132 - 147 | mmol/L |
| 1882 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Serum Potassium | | 5.0 | | | | | 3.5 - 5.2 | mmol/L |
| 1883 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Serum Bicarbonate | | 25.7 | | | | | 19.3 - 29.3 | mmol/L |
| 1884 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | CHEMISTRY PANEL | Serum Chloride | | 101 | | | | | 94 - 112 | mmol/L |
| 1885 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 154 | | | | | 116 - 164 | g/L |
| 1886 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.46 | | | | | 0.34 - 0.48 | |
| 1887 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.1 | | | | | 4.1 - 5.6 | TI/L |
| 1888 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1889 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 90 | | | | | 79 - 98 | fL |
| 1890 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 8.24 | | | | | 3.8 - 10.7 | GI/L |
| 1891 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 5.24 | | | | | 1.96 - 7.23 | GI/L |
| 1892 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.33 | | | | | 0.91 - 4.28 | GI/L |
| 1893 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.45 | | | | | 0.12 - 0.92 | GI/L |
| 1894 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 1895 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.06 | | | | | 0 - 0.2 | GI/L |
| 1896 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 63.6 | | | | | 40.5 - 75 | % |
| 1897 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 28.3 | | | | | 15.4 - 48.5 | % |
| 1898 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.4 | | | | | 2.6 - 10.1 | % |
| 1899 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 1.9 | | | | | 0 - 6.8 | % |
| 1900 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.8 | | | | | 0 - 2 | % |
| 1901 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 330 | | | | | 140 - 400 | GI/L |
| 1902 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | | 6.1 | | | | | <6.5 % | |
| 1903 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 14.65 | | | | | 1.9 - 23 | uIU/mL |
| 1904 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1905 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.03 | | | | | 1.03 - 1.53 | mmol/L |
| 1906 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | LIPID PANEL | Triglycerides (GPO) | | 1.18 | | | | | 0.59 - 2.96 | mmol/L |
| 1907 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | LIPID PANEL | Cholesterol (High Performance) | | 2.69 | | L | | | 4.42 - 7.53 | mmol/L |
| 1908 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.12 | | | | | 0 - 3.34 | mmol/L |
| 1909 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | RETICULOCYTES | Reticulocyte Count % | | 2.1 | | | | | 0.6 - 2.5 | % |
| 1910 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | TSH | TSH 3rd IS-QT | | 1.264 | | | | | 0.45 - 5.33 | mIU/L |
| 1911 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Specific Gravity | | 1.021 | | | | | 1 - 1.04 | |
| 1912 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 1913 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1914 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1915 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1916 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1917 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1918 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1919 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1920 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +3 | | H SF | | | Ref Rng:Negative | |
| 1921 | CZ100040003 | | | 55 | years | Female | Part 2 OL Induction Baseline | | Dec 19, 2025 9:25 AM | 6227106906 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1922 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.8 | | | | | 0 - 5 | mg/L |
| 1923 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CELLULAR ELEMENTS | Ur WBC/HPF | | 2 | | | | | 0 - 12 | /HPF |
| 1924 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Total Bilirubin | | 10 | | | | | 3 - 21 | umol/L |
| 1925 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.0 | | | | | 0 - 6.2 | umol/L |
| 1926 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Alkaline Phosphatase | | 85 | | | | | 35 - 104 | U/L |
| 1927 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | ALT (SGPT) | | 20 | | | | | 4 - 43 | U/L |
| 1928 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | AST (SGOT) | | 18 | | | | | 8 - 40 | U/L |
| 1929 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | GGT | | 22 | | | | | 4 - 49 | U/L |
| 1930 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | LDH | | 199 | | | | | 53 - 234 | U/L |
| 1931 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Urea Nitrogen | | 3.6 | | | | | 1.4 - 8.6 | mmol/L |
| 1932 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 69 | | | | | 31 - 101 | umol/L |
| 1933 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Glucose Fasting | | 5.0 | | | | | 3.9 - 5.6 | mmol/L |
| 1934 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Serum Uric Acid | | 242 | | | | | 149 - 446 | umol/L |
| 1935 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.44 | | | | | 2.07 - 2.64 | mmol/L |
| 1936 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Phosphorus | | 1.18 | | | | | 0.71 - 1.65 | mmol/L |
| 1937 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Total Protein | | 70 | | | | | 61 - 84 | g/L |
| 1938 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Albumin-BCG | | 44 | | | | | 33 - 49 | g/L |
| 1939 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Creatine Kinase | | 113 | | | | | 26 - 192 | U/L |
| 1940 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 132 - 147 | mmol/L |
| 1941 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Serum Potassium | | 4.5 | | | | | 3.5 - 5.2 | mmol/L |
| 1942 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Serum Bicarbonate | | 29.7 | | H | | | 19.3 - 29.3 | mmol/L |
| 1943 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | CHEMISTRY PANEL | Serum Chloride | | 101 | | | | | 94 - 112 | mmol/L |
| 1944 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 136 | | | | | 116 - 164 | g/L |
| 1945 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.41 | | | | | 0.34 - 0.48 | |
| 1946 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.4 | | | | | 4.1 - 5.6 | TI/L |
| 1947 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 1948 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 93 | | | | | 79 - 98 | fL |
| 1949 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.80 | | | | | 3.8 - 10.7 | GI/L |
| 1950 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.73 | | | | | 1.96 - 7.23 | GI/L |
| 1951 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.58 | | | | | 0.91 - 4.28 | GI/L |
| 1952 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.36 | | | | | 0.12 - 0.92 | GI/L |
| 1953 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.10 | | | | | 0 - 0.57 | GI/L |
| 1954 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.02 | | | | | 0 - 0.2 | GI/L |
| 1955 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 56.9 | | | | | 40.5 - 75 | % |
| 1956 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 32.9 | | | | | 15.4 - 48.5 | % |
| 1957 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 7.6 | | | | | 2.6 - 10.1 | % |
| 1958 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.2 | | | | | 0 - 6.8 | % |
| 1959 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.4 | | | | | 0 - 2 | % |
| 1960 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 308 | | | | | 140 - 400 | GI/L |
| 1961 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 1.74 | | L | | | 1.9 - 23 | uIU/mL |
| 1962 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 1963 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.50 | | | | | 1.03 - 1.53 | mmol/L |
| 1964 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | LIPID PANEL | Triglycerides (GPO) | | 0.88 | | | | | 0.59 - 2.96 | mmol/L |
| 1965 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | LIPID PANEL | Cholesterol (High Performance) | | 5.66 | | | | | 4.42 - 7.53 | mmol/L |
| 1966 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.76 | | H | | | 0 - 3.34 | mmol/L |
| 1967 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | RETICULOCYTES | Reticulocyte Count % | | 1.3 | | | | | 0.6 - 2.5 | % |
| 1968 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Specific Gravity | | 1.016 | | | | | 1 - 1.04 | |
| 1969 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur pH | | 7.5 | | | | | 5 - 8 | |
| 1970 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 1971 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 1972 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 1973 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 1974 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 1975 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 1976 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 1977 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Trace | | H | | | Ref Rng:Negative | |
| 1978 | CZ100040004 | | | 54 | years | Female | Part 1 DB Baseline | | Dec 5, 2025 7:55 AM | 6227261230 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 1979 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 3.0 | | | | | 0 - 5 | mg/L |
| 1980 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Total Bilirubin | | 7 | | | | | 3 - 21 | umol/L |
| 1981 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.3 | | | | | 0 - 6.2 | umol/L |
| 1982 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Alkaline Phosphatase | | 72 | | | | | 35 - 104 | U/L |
| 1983 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | ALT (SGPT) | | 19 | | | | | 4 - 43 | U/L |
| 1984 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | AST (SGOT) | | 18 | | | | | 8 - 40 | U/L |
| 1985 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | GGT | | 45 | | | | | 4 - 49 | U/L |
| 1986 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | LDH | | 135 | | | | | 53 - 234 | U/L |
| 1987 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Urea Nitrogen | | 4.2 | | | | | 1.4 - 8.6 | mmol/L |
| 1988 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 59 | | | | | 31 - 101 | umol/L |
| 1989 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Glucose Fasting | | 5.1 | | | | | 3.9 - 5.6 | mmol/L |
| 1990 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Serum Uric Acid | | 277 | | | | | 125 - 428 | umol/L |
| 1991 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.35 | | | | | 2.07 - 2.64 | mmol/L |
| 1992 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Phosphorus | | 1.06 | | | | | 0.71 - 1.65 | mmol/L |
| 1993 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Total Protein | | 73 | | | | | 61 - 84 | g/L |
| 1994 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Albumin-BCG | | 44 | | | | | 33 - 49 | g/L |
| 1995 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Creatine Kinase | | 94 | | | | | 26 - 192 | U/L |
| 1996 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Serum Sodium | | 138 | | | | | 132 - 147 | mmol/L |
| 1997 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Serum Potassium | | 4.8 | | | | | 3.5 - 5.2 | mmol/L |
| 1998 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.2 | | | | | 19.3 - 29.3 | mmol/L |
| 1999 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 2000 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 125 | | | | | 116 - 164 | g/L |
| 2001 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.38 | | | | | 0.34 - 0.48 | |
| 2002 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.0 | R | L | | | 4.1 - 5.6 | TI/L |
| 2003 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2004 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 2005 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 6.92 | | | | | 3.8 - 10.7 | GI/L |
| 2006 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 3.08 | | | | | 1.96 - 7.23 | GI/L |
| 2007 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.93 | | | | | 0.91 - 4.28 | GI/L |
| 2008 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.56 | | | | | 0.12 - 0.92 | GI/L |
| 2009 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.31 | | | | | 0 - 0.57 | GI/L |
| 2010 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.04 | | | | | 0 - 0.2 | GI/L |
| 2011 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 44.5 | | | | | 40.5 - 75 | % |
| 2012 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 42.3 | | | | | 15.4 - 48.5 | % |
| 2013 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 8.1 | | | | | 2.6 - 10.1 | % |
| 2014 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 4.4 | | | | | 0 - 6.8 | % |
| 2015 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.6 | | | | | 0 - 2 | % |
| 2016 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 304 | | | | | 140 - 400 | GI/L |
| 2017 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 7.03 | | | | | 1.9 - 23 | uIU/mL |
| 2018 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2019 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.36 | | | | | 1.03 - 1.53 | mmol/L |
| 2020 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | LIPID PANEL | Triglycerides (GPO) | | 2.05 | | | | | 0.51 - 2.42 | mmol/L |
| 2021 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | LIPID PANEL | Cholesterol (High Performance) | | 5.46 | | | | | 4.01 - 6.85 | mmol/L |
| 2022 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.16 | | | | | 0 - 3.34 | mmol/L |
| 2023 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | RETICULOCYTES | Reticulocyte Count % | | 1.8 | | | | | 0.6 - 2.5 | % |
| 2024 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | TSH | TSH 3rd IS-QT | | 1.135 | | | | | 0.45 - 5.33 | mIU/L |
| 2025 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Specific Gravity | | 1.023 | | | | | 1 - 1.04 | |
| 2026 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 2027 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 2028 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2029 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2030 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2031 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2032 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2033 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2034 | CZ100040002 | | | 46 | years | Female | Part 2 OL Induction Baseline | | Nov 28, 2025 9:00 AM | 6227106905 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 2035 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.7 | | | | | 0 - 5 | mg/L |
| 2036 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 2037 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.8 | | | | | 0 - 6.2 | umol/L |
| 2038 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Alkaline Phosphatase | | 100 | | | | | 35 - 104 | U/L |
| 2039 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | ALT (SGPT) | | 29 | | | | | 4 - 43 | U/L |
| 2040 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | AST (SGOT) | | 33 | | | | | 8 - 40 | U/L |
| 2041 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | GGT | | 17 | | | | | 4 - 49 | U/L |
| 2042 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | LDH | | 257 | | H | | | 53 - 234 | U/L |
| 2043 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Urea Nitrogen | | 5.1 | | | | | 1.4 - 8.6 | mmol/L |
| 2044 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 72 | | | | | 31 - 101 | umol/L |
| 2045 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Glucose Fasting | | 5.1 | | | | | 3.9 - 5.6 | mmol/L |
| 2046 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Serum Uric Acid | | 318 | | | | | 149 - 446 | umol/L |
| 2047 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.35 | | | | | 2.07 - 2.64 | mmol/L |
| 2048 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Phosphorus | | 1.06 | | | | | 0.71 - 1.65 | mmol/L |
| 2049 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Total Protein | | 72 | | | | | 61 - 84 | g/L |
| 2050 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Albumin-BCG | | 47 | | | | | 33 - 49 | g/L |
| 2051 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Creatine Kinase | | 276 | | H | | | 26 - 192 | U/L |
| 2052 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 132 - 147 | mmol/L |
| 2053 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Serum Potassium | | 4.4 | | | | | 3.5 - 5.2 | mmol/L |
| 2054 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Serum Bicarbonate | | 24.3 | | | | | 19.3 - 29.3 | mmol/L |
| 2055 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 2056 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 137 | | | | | 116 - 164 | g/L |
| 2057 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.40 | | | | | 0.34 - 0.48 | |
| 2058 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.6 | | | | | 4.1 - 5.6 | TI/L |
| 2059 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2060 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 87 | | | | | 79 - 98 | fL |
| 2061 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.48 | | | | | 3.8 - 10.7 | GI/L |
| 2062 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.40 | | | | | 1.96 - 7.23 | GI/L |
| 2063 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.48 | | | | | 0.91 - 4.28 | GI/L |
| 2064 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.49 | | | | | 0.12 - 0.92 | GI/L |
| 2065 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.10 | | | | | 0 - 0.57 | GI/L |
| 2066 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.01 | | | | | 0 - 0.2 | GI/L |
| 2067 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 53.5 | | | | | 40.5 - 75 | % |
| 2068 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 33.1 | | | | | 15.4 - 48.5 | % |
| 2069 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 10.9 | R | H | | | 2.6 - 10.1 | % |
| 2070 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.3 | | | | | 0 - 6.8 | % |
| 2071 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.2 | | | | | 0 - 2 | % |
| 2072 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 143 | | | | | 140 - 400 | GI/L |
| 2073 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.90 | | | | | 1.9 - 23 | uIU/mL |
| 2074 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2075 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.12 | | | | | 1.03 - 1.53 | mmol/L |
| 2076 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | LIPID PANEL | Triglycerides (GPO) | | 1.26 | | | | | 0.59 - 2.96 | mmol/L |
| 2077 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | LIPID PANEL | Cholesterol (High Performance) | | 5.71 | | | | | 4.42 - 7.53 | mmol/L |
| 2078 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.01 | | H | | | 0 - 3.34 | mmol/L |
| 2079 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | RETICULOCYTES | Reticulocyte Count % | | 1.8 | | | | | 0.6 - 2.5 | % |
| 2080 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Specific Gravity | | 1.020 | | | | | 1 - 1.04 | |
| 2081 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 2082 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 2083 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2084 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2085 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2086 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2087 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2088 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2089 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Day 29 | | Nov 14, 2025 9:10 AM | 6227043302 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 2090 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.7 | | | | | 0 - 5 | mg/L |
| 2091 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CELLULAR ELEMENTS | Ur WBC/HPF | | 10 | | | | | 0 - 12 | /HPF |
| 2092 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Total Bilirubin | | 14 | | | | | 3 - 21 | umol/L |
| 2093 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 5.2 | | | | | 0 - 6.2 | umol/L |
| 2094 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Alkaline Phosphatase | | 91 | | | | | 35 - 104 | U/L |
| 2095 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | ALT (SGPT) | | 49 | | H | | | 4 - 43 | U/L |
| 2096 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | AST (SGOT) | | 31 | | | | | 8 - 40 | U/L |
| 2097 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | GGT | | 22 | | | | | 4 - 49 | U/L |
| 2098 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | LDH | | 176 | | | | | 53 - 234 | U/L |
| 2099 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Urea Nitrogen | | 5.0 | | | | | 1.4 - 8.6 | mmol/L |
| 2100 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 75 | | | | | 31 - 101 | umol/L |
| 2101 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Glucose Fasting | | 6.8 | | H | | | 3.9 - 5.6 | mmol/L |
| 2102 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Serum Uric Acid | | 282 | | | | | 149 - 446 | umol/L |
| 2103 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.46 | | | | | 2.07 - 2.64 | mmol/L |
| 2104 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Phosphorus | | 1.34 | | | | | 0.71 - 1.65 | mmol/L |
| 2105 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Total Protein | | 67 | | | | | 61 - 84 | g/L |
| 2106 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 2107 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Creatine Kinase | | 51 | | | | | 26 - 192 | U/L |
| 2108 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 2109 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Serum Potassium | | 5.1 | | | | | 3.5 - 5.2 | mmol/L |
| 2110 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Serum Bicarbonate | | 22.7 | | | | | 19.3 - 29.3 | mmol/L |
| 2111 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 2112 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 147 | | | | | 116 - 164 | g/L |
| 2113 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.44 | | | | | 0.34 - 0.48 | |
| 2114 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.9 | | | | | 4.1 - 5.6 | TI/L |
| 2115 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2116 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 89 | | | | | 79 - 98 | fL |
| 2117 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 7.87 | | | | | 3.8 - 10.7 | GI/L |
| 2118 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.64 | | | | | 1.96 - 7.23 | GI/L |
| 2119 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.53 | | | | | 0.91 - 4.28 | GI/L |
| 2120 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.42 | | | | | 0.12 - 0.92 | GI/L |
| 2121 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.20 | | | | | 0 - 0.57 | GI/L |
| 2122 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.07 | | | | | 0 - 0.2 | GI/L |
| 2123 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.9 | | | | | 40.5 - 75 | % |
| 2124 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 32.3 | | | | | 15.4 - 48.5 | % |
| 2125 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 5.4 | | | | | 2.6 - 10.1 | % |
| 2126 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.5 | | | | | 0 - 6.8 | % |
| 2127 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.9 | | | | | 0 - 2 | % |
| 2128 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 294 | | | | | 140 - 400 | GI/L |
| 2129 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 12.54 | | | | | 1.9 - 23 | uIU/mL |
| 2130 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2131 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | LIPID PANEL | Direct HDL-C 4th Generation | | 0.96 | | L | | | 1.03 - 1.53 | mmol/L |
| 2132 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | LIPID PANEL | Triglycerides (GPO) | | 0.90 | | | | | 0.59 - 2.96 | mmol/L |
| 2133 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | LIPID PANEL | Cholesterol (High Performance) | | 2.39 | | L | | Result verified by repeat analysis | 4.42 - 7.53 | mmol/L |
| 2134 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.02 | | | | | 0 - 3.34 | mmol/L |
| 2135 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 2136 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | RETICULOCYTES | Reticulocyte Count % | | 1.6 | | | | | 0.6 - 2.5 | % |
| 2137 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Specific Gravity | | 1.017 | | | | | 1 - 1.04 | |
| 2138 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 2139 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 2140 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2141 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2142 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2143 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2144 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2145 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2146 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +2 | | H SF | | | Ref Rng:Negative | |
| 2147 | CZ100040003 | | | 55 | years | Female | Part 1 DB Baseline | | Nov 7, 2025 9:30 AM | 6225350982 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 2148 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.3 | | | | | 0 - 5 | mg/L |
| 2149 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CELLULAR ELEMENTS | Ur RBC/HPF | | 1 | | | | | 0 - 8 | /HPF |
| 2150 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CELLULAR ELEMENTS | Ur WBC/HPF | | 7 | | | | | 0 - 12 | /HPF |
| 2151 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Total Bilirubin | | 11 | | | | | 3 - 21 | umol/L |
| 2152 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 3.5 | | | | | 0 - 6.2 | umol/L |
| 2153 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Alkaline Phosphatase | | 84 | | | | | 35 - 104 | U/L |
| 2154 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | ALT (SGPT) | | 18 | | | | | 4 - 43 | U/L |
| 2155 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | AST (SGOT) | | 19 | | | | | 8 - 40 | U/L |
| 2156 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | GGT | | 21 | | | | | 4 - 49 | U/L |
| 2157 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | LDH | | 206 | | | | | 53 - 234 | U/L |
| 2158 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Urea Nitrogen | | 4.0 | | | | | 1.4 - 8.6 | mmol/L |
| 2159 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 78 | | | | | 31 - 101 | umol/L |
| 2160 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Glucose Fasting | | 5.5 | | | | | 3.9 - 5.6 | mmol/L |
| 2161 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Serum Uric Acid | | 260 | | | | | 149 - 446 | umol/L |
| 2162 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.42 | | | | | 2.07 - 2.64 | mmol/L |
| 2163 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Phosphorus | | 1.17 | | | | | 0.71 - 1.65 | mmol/L |
| 2164 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Total Protein | | 68 | | | | | 61 - 84 | g/L |
| 2165 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 2166 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Creatine Kinase | | 107 | | | | | 26 - 192 | U/L |
| 2167 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 132 - 147 | mmol/L |
| 2168 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Serum Potassium | | 4.2 | | | | | 3.5 - 5.2 | mmol/L |
| 2169 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Serum Bicarbonate | | 22.4 | | | | | 19.3 - 29.3 | mmol/L |
| 2170 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 2171 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.58 | | | | | 1.25 - 1.92 | mL/sec |
| 2172 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 78 | | | | | 31 - 101 | umol/L |
| 2173 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 81.6 | | | | | kg | |
| 2174 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 2175 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 2176 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 2177 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2178 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2179 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2180 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 2181 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | | | | | | |
| 2182 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | GFR | EGFR by MDRD | | 67 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 2183 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 136 | | | | | 116 - 164 | g/L |
| 2184 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.41 | | | | | 0.34 - 0.48 | |
| 2185 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.4 | | | | | 4.1 - 5.6 | TI/L |
| 2186 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2187 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 93 | | | | | 79 - 98 | fL |
| 2188 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.09 | | | | | 3.8 - 10.7 | GI/L |
| 2189 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.99 | | | | | 1.96 - 7.23 | GI/L |
| 2190 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.48 | | | | | 0.91 - 4.28 | GI/L |
| 2191 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.34 | | | | | 0.12 - 0.92 | GI/L |
| 2192 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 2193 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.12 | | | | | 0 - 0.2 | GI/L |
| 2194 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.8 | | | | | 40.5 - 75 | % |
| 2195 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 29.2 | | | | | 15.4 - 48.5 | % |
| 2196 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.7 | | | | | 2.6 - 10.1 | % |
| 2197 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 3.0 | | | | | 0 - 6.8 | % |
| 2198 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 2.3 | | H | | | 0 - 2 | % |
| 2199 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 313 | | | | | 140 - 400 | GI/L |
| 2200 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | | 5.1 | | | | | <6.5% | |
| 2201 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 4.19 | | | | | 1.9 - 23 | uIU/mL |
| 2202 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2203 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 2204 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.52 | | | | | 1.03 - 1.53 | mmol/L |
| 2205 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | LIPID PANEL | Triglycerides (GPO) | | 1.01 | | | | | 0.59 - 2.96 | mmol/L |
| 2206 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | LIPID PANEL | Cholesterol (High Performance) | | 5.29 | | | | | 4.42 - 7.53 | mmol/L |
| 2207 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.31 | | | | | 0 - 3.34 | mmol/L |
| 2208 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | No | | | | | | |
| 2209 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | RETICULOCYTES | Reticulocyte Count % | | 1.4 | | | | | 0.6 - 2.5 | % |
| 2210 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | TSH | TSH 3rd IS-QT | | 1.461 | | | | | 0.45 - 5.33 | mIU/L |
| 2211 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Specific Gravity | | 1.024 | | | | | 1 - 1.04 | |
| 2212 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur pH | | 6.5 | | | | | 5 - 8 | |
| 2213 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Protein | | Trace | R | H | | | Ref Rng:Negative | |
| 2214 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2215 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2216 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2217 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2218 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2219 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2220 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 2221 | CZ100040004 | | | 54 | years | Female | Part 1 Screening | | Nov 7, 2025 8:10 AM | 6225350975 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 2222 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 3.5 | | | | | 0 - 5 | mg/L |
| 2223 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Total Bilirubin | | 9 | | | | | 3 - 21 | umol/L |
| 2224 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.7 | | | | | 0 - 6.2 | umol/L |
| 2225 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Alkaline Phosphatase | | 77 | | | | | 35 - 104 | U/L |
| 2226 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | ALT (SGPT) | | 27 | | | | | 4 - 43 | U/L |
| 2227 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | AST (SGOT) | | 25 | | | | | 8 - 40 | U/L |
| 2228 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | GGT | | 45 | | | | | 4 - 49 | U/L |
| 2229 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | LDH | | 161 | | | | | 53 - 234 | U/L |
| 2230 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Urea Nitrogen | | 3.5 | | | | | 1.4 - 8.6 | mmol/L |
| 2231 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 63 | | | | | 31 - 101 | umol/L |
| 2232 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 2233 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Serum Uric Acid | | 261 | | | | | 125 - 428 | umol/L |
| 2234 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 2235 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Phosphorus | | 1.12 | | | | | 0.71 - 1.65 | mmol/L |
| 2236 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Total Protein | | 71 | | | | | 61 - 84 | g/L |
| 2237 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Albumin-BCG | | 44 | | | | | 33 - 49 | g/L |
| 2238 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Creatine Kinase | | 99 | | | | | 26 - 192 | U/L |
| 2239 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 132 - 147 | mmol/L |
| 2240 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Serum Potassium | | 4.7 | | | | | 3.5 - 5.2 | mmol/L |
| 2241 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Serum Bicarbonate | | 21.9 | | | | | 19.3 - 29.3 | mmol/L |
| 2242 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | CHEMISTRY PANEL | Serum Chloride | | 105 | | | | | 94 - 112 | mmol/L |
| 2243 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 126 | | | | | 116 - 164 | g/L |
| 2244 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.39 | | | | | 0.34 - 0.48 | |
| 2245 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.1 | | | | | 4.1 - 5.6 | TI/L |
| 2246 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2247 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 96 | | | | | 79 - 98 | fL |
| 2248 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 7.55 | | | | | 3.8 - 10.7 | GI/L |
| 2249 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 4.59 | | | | | 1.96 - 7.23 | GI/L |
| 2250 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.09 | | | | | 0.91 - 4.28 | GI/L |
| 2251 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.63 | | | | | 0.12 - 0.92 | GI/L |
| 2252 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.20 | | | | | 0 - 0.57 | GI/L |
| 2253 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.03 | | | | | 0 - 0.2 | GI/L |
| 2254 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 60.9 | | | | | 40.5 - 75 | % |
| 2255 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 27.7 | | | | | 15.4 - 48.5 | % |
| 2256 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 8.3 | | | | | 2.6 - 10.1 | % |
| 2257 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.6 | | | | | 0 - 6.8 | % |
| 2258 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.5 | | | | | 0 - 2 | % |
| 2259 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 324 | | | | | 140 - 400 | GI/L |
| 2260 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 5.08 | | | | | 1.9 - 23 | uIU/mL |
| 2261 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2262 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.54 | | H | | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L |
| 2263 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | LIPID PANEL | Triglycerides (GPO) | | 2.08 | | | | | 0.51 - 2.42 | mmol/L |
| 2264 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | LIPID PANEL | Cholesterol (High Performance) | | 5.37 | | | | | 4.01 - 6.85 | mmol/L |
| 2265 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | LIPID PANEL | LDL Chol Friedewald 4th | | 2.88 | | | | | 0 - 3.34 | mmol/L |
| 2266 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | RETICULOCYTES | Reticulocyte Count % | | 2.1 | | | | | 0.6 - 2.5 | % |
| 2267 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Specific Gravity | | 1.017 | | | | | 1 - 1.04 | |
| 2268 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 2269 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 2270 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2271 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2272 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2273 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2274 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2275 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2276 | CZ100040002 | | | 46 | years | Female | Part 1 DB Baseline | | Oct 17, 2025 10:45 AM | 6225350984 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 2277 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 1.5 | | | | | 0 - 5 | mg/L |
| 2278 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CELLULAR ELEMENTS | Ur WBC/HPF | | 5 | | | | | 0 - 12 | /HPF |
| 2279 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Total Bilirubin | | 7 | | | | | 3 - 21 | umol/L |
| 2280 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.0 | | | | | 0 - 6.2 | umol/L |
| 2281 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Alkaline Phosphatase | | 99 | | | | | 35 - 104 | U/L |
| 2282 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | ALT (SGPT) | | 32 | | | | | 4 - 43 | U/L |
| 2283 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | AST (SGOT) | | 32 | | | | | 8 - 40 | U/L |
| 2284 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | GGT | | 18 | | | | | 4 - 49 | U/L |
| 2285 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | LDH | | 232 | | | | | 53 - 234 | U/L |
| 2286 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Urea Nitrogen | | 4.7 | | | | | 1.4 - 8.6 | mmol/L |
| 2287 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 77 | | | | | 31 - 101 | umol/L |
| 2288 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Glucose Fasting | | 5.3 | | | | | 3.9 - 5.6 | mmol/L |
| 2289 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Serum Uric Acid | | 392 | | | | | 149 - 446 | umol/L |
| 2290 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.37 | | | | | 2.07 - 2.64 | mmol/L |
| 2291 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Phosphorus | | 1.06 | | | | | 0.71 - 1.65 | mmol/L |
| 2292 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Total Protein | | 73 | | | | | 61 - 84 | g/L |
| 2293 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 2294 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Creatine Kinase | | 160 | | | | | 26 - 192 | U/L |
| 2295 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Serum Sodium | | 140 | | | | | 132 - 147 | mmol/L |
| 2296 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Serum Potassium | | 4.4 | | | | | 3.5 - 5.2 | mmol/L |
| 2297 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Serum Bicarbonate | | 23.1 | | | | | 19.3 - 29.3 | mmol/L |
| 2298 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 2299 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 143 | | | | | 116 - 164 | g/L |
| 2300 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.41 | | | | | 0.34 - 0.48 | |
| 2301 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.7 | | | | | 4.1 - 5.6 | TI/L |
| 2302 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | Normocytic | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2303 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 88 | | | | | 79 - 98 | fL |
| 2304 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 4.39 | | | | | 3.8 - 10.7 | GI/L |
| 2305 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.58 | | | | | 1.96 - 7.23 | GI/L |
| 2306 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 1.36 | | | | | 0.91 - 4.28 | GI/L |
| 2307 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.31 | | | | | 0.12 - 0.92 | GI/L |
| 2308 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.13 | | | | | 0 - 0.57 | GI/L |
| 2309 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.02 | | | | | 0 - 0.2 | GI/L |
| 2310 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 58.8 | | | | | 40.5 - 75 | % |
| 2311 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 30.9 | | | | | 15.4 - 48.5 | % |
| 2312 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 7.1 | | | | | 2.6 - 10.1 | % |
| 2313 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.9 | | | | | 0 - 6.8 | % |
| 2314 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.4 | | | | | 0 - 2 | % |
| 2315 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | | | | Test cancelled: Platelet clumps present | | | |
| 2316 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | | 5.8 | | | | | <6.5% | |
| 2317 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | | | | Test cancelled: Hemolysis-test not performed | | | |
| 2318 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2319 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.11 | | | | | 1.03 - 1.53 | mmol/L |
| 2320 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | LIPID PANEL | Triglycerides (GPO) | | 1.60 | | | | | 0.59 - 2.96 | mmol/L |
| 2321 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | LIPID PANEL | Cholesterol (High Performance) | | 6.83 | | | | | 4.42 - 7.53 | mmol/L |
| 2322 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | LIPID PANEL | LDL Chol Friedewald 4th | | 4.99 | | H | | | 0 - 3.34 | mmol/L |
| 2323 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 2324 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | RETICULOCYTES | Reticulocyte Count % | | 1.7 | | | | | 0.6 - 2.5 | % |
| 2325 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | TSH | TSH 3rd IS-QT | | 2.025 | | | | | 0.45 - 5.33 | mIU/L |
| 2326 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Specific Gravity | | 1.018 | | | | | 1 - 1.04 | |
| 2327 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur pH | | 7.0 | | | | | 5 - 8 | |
| 2328 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 2329 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2330 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2331 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2332 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2333 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2334 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2335 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Trace | R | H | | | Ref Rng:Negative | |
| 2336 | CZ100040001 | | | 56 | years | Female | Part 2 OL Induction Baseline | | Oct 17, 2025 9:00 AM | 6225350988 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 2337 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 3.9 | | | | | 0 - 5 | mg/L |
| 2338 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CELLULAR ELEMENTS | Ur WBC/HPF | | 42 | | H | | | 0 - 12 | /HPF |
| 2339 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Total Bilirubin | | 13 | | | | | 3 - 21 | umol/L |
| 2340 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 4.7 | | | | | 0 - 6.2 | umol/L |
| 2341 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Alkaline Phosphatase | | 83 | | | | | 35 - 104 | U/L |
| 2342 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | ALT (SGPT) | | 69 | | H RX | | | 4 - 43 | U/L |
| 2343 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | AST (SGOT) | | 40 | | | | | 8 - 40 | U/L |
| 2344 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | GGT | | 27 | | | | | 4 - 49 | U/L |
| 2345 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | LDH | | 190 | | | | | 53 - 234 | U/L |
| 2346 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Urea Nitrogen | | 3.8 | | | | | 1.4 - 8.6 | mmol/L |
| 2347 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 72 | | | | | 31 - 101 | umol/L |
| 2348 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Glucose Fasting | | 7.5 | | H | | | 3.9 - 5.6 | mmol/L |
| 2349 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Serum Uric Acid | | 309 | | | | | 149 - 446 | umol/L |
| 2350 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.40 | | | | | 2.07 - 2.64 | mmol/L |
| 2351 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Phosphorus | | 1.28 | | | | | 0.71 - 1.65 | mmol/L |
| 2352 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Total Protein | | 66 | | | | | 61 - 84 | g/L |
| 2353 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
| 2354 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Creatine Kinase | | 48 | | | | | 26 - 192 | U/L |
| 2355 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Serum Sodium | | 141 | | | | | 132 - 147 | mmol/L |
| 2356 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Serum Potassium | | 4.2 | | | | | 3.5 - 5.2 | mmol/L |
| 2357 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Serum Bicarbonate | | 24.7 | | | | | 19.3 - 29.3 | mmol/L |
| 2358 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CHEMISTRY PANEL | Serum Chloride | | 104 | | | | | 94 - 112 | mmol/L |
| 2359 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.65 | | | | | 1.25 - 1.92 | mL/sec |
| 2360 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 72 | | | | | 31 - 101 | umol/L |
| 2361 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 79.2 | | | | | kg | |
| 2362 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 2363 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 2364 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | | Neg;$Cutoff = 50 ng/mL | |
| 2365 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2366 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2367 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2368 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 2369 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | | | | | | |
| 2370 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | GFR | EGFR by MDRD | | 74 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 2371 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 151 | | | | | 116 - 164 | g/L |
| 2372 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.45 | | | | | 0.34 - 0.48 | |
| 2373 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 5.0 | | | | | 4.1 - 5.6 | TI/L |
| 2374 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2375 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 91 | | | | | 79 - 98 | fL |
| 2376 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 9.69 | | | | | 3.8 - 10.7 | GI/L |
| 2377 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 6.48 | | | | | 1.96 - 7.23 | GI/L |
| 2378 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.44 | | | | | 0.91 - 4.28 | GI/L |
| 2379 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.48 | | | | | 0.12 - 0.92 | GI/L |
| 2380 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.23 | | | | | 0 - 0.57 | GI/L |
| 2381 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.07 | | | | | 0 - 0.2 | GI/L |
| 2382 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 66.8 | | | | | 40.5 - 75 | % |
| 2383 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 25.1 | | | | | 15.4 - 48.5 | % |
| 2384 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 4.9 | | | | | 2.6 - 10.1 | % |
| 2385 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.3 | | | | | 0 - 6.8 | % |
| 2386 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 0.8 | | | | | 0 - 2 | % |
| 2387 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 324 | | | | | 140 - 400 | GI/L |
| 2388 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | | 6.6 | | H | | | <6.5% | |
| 2389 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 13.86 | | | | | 1.9 - 23 | uIU/mL |
| 2390 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2391 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 2392 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | LIPID PANEL | Direct HDL-C 4th Generation | | 0.89 | | L | | | 1.03 - 1.53 | mmol/L |
| 2393 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | LIPID PANEL | Triglycerides (GPO) | | 1.13 | | | | | 0.59 - 2.96 | mmol/L |
| 2394 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | LIPID PANEL | Cholesterol (High Performance) | | 2.44 | | L | | Result verified by repeat analysis | 4.42 - 7.53 | mmol/L |
| 2395 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | LIPID PANEL | LDL Chol Friedewald 4th | | 1.03 | | | | | 0 - 3.34 | mmol/L |
| 2396 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | MICROORGANISMS | Ur Bacteria | | Present | | | | | Ref Rng:Not present | |
| 2397 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | MISCELLANEOUS ELEMENTS | Ur Mucous | | Present | | | | | Ref Rng:Not present | |
| 2398 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | No | | | | | | |
| 2399 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | RETICULOCYTES | Reticulocyte Count % | | 2.0 | | | | | 0.6 - 2.5 | % |
| 2400 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | TSH | TSH 3rd IS-QT | | 1.524 | | | | | 0.45 - 5.33 | mIU/L |
| 2401 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Specific Gravity | | 1.024 | | | | | 1 - 1.04 | |
| 2402 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur pH | | 5.5 | | | | | 5 - 8 | |
| 2403 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Protein | | Trace | | H | | | Ref Rng:Negative | |
| 2404 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2405 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2406 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2407 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2408 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2409 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2410 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MACRO PANEL | Ur Leukocyte Esterase | | +3 | | H SF | | | Ref Rng:Negative | |
| 2411 | CZ100040003 | | | 55 | years | Female | Part 1 Screening | | Oct 10, 2025 9:20 AM | 6225350977 | URINE MICRO PANEL | Ur Microscopic | | Positive | | | | | NEGATIVE$ | NEGATIVE |
| 2412 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.1 | | | | | 0 - 5 | mg/L |
| 2413 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Total Bilirubin | | 10 | | | | | 3 - 21 | umol/L |
| 2414 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 2.9 | | | | | 0 - 6.2 | umol/L |
| 2415 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Alkaline Phosphatase | | 82 | | | | | 35 - 104 | U/L |
| 2416 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | ALT (SGPT) | | 23 | | | | | 4 - 43 | U/L |
| 2417 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | AST (SGOT) | | 23 | | | | | 8 - 40 | U/L |
| 2418 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | GGT | | 47 | | | | | 4 - 49 | U/L |
| 2419 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | LDH | | 153 | | | | | 53 - 234 | U/L |
| 2420 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Urea Nitrogen | | 4.3 | | | | | 1.4 - 8.6 | mmol/L |
| 2421 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 69 | | | | | 31 - 101 | umol/L |
| 2422 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 2423 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Serum Uric Acid | | 322 | | | | | 125 - 428 | umol/L |
| 2424 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.47 | | | | | 2.07 - 2.64 | mmol/L |
| 2425 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Phosphorus | | 1.05 | | | | | 0.71 - 1.65 | mmol/L |
| 2426 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Total Protein | | 79 | | | | | 61 - 84 | g/L |
| 2427 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Albumin-BCG | | 48 | | | | | 33 - 49 | g/L |
| 2428 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Creatine Kinase | | 104 | | | | | 26 - 192 | U/L |
| 2429 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Serum Sodium | | 139 | | | | | 132 - 147 | mmol/L |
| 2430 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Serum Potassium | | 4.8 | | | | | 3.5 - 5.2 | mmol/L |
| 2431 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Serum Bicarbonate | | 22.9 | | | | | 19.3 - 29.3 | mmol/L |
| 2432 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CHEMISTRY PANEL | Serum Chloride | | 102 | | | | | 94 - 112 | mmol/L |
| 2433 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | | 1.88 | | | | | 1.25 - 1.92 | mL/sec |
| 2434 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | | 69 | | | | | 31 - 101 | umol/L |
| 2435 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 78.6 | | | | | kg | |
| 2436 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE | Amphetamines/MDMA | | Neg | | | | | Neg;$Cutoff = 1000 ng/mL | |
| 2437 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE | Barbiturates | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 2438 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE | Cannabinoids | | Neg | | | | Result verified by repeat analysis | Neg;$Cutoff = 50 ng/mL | |
| 2439 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE | Cocaine | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2440 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE | Opiates | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2441 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE | Methadone | | Neg | | | | | Neg;$Cutoff = 300 ng/mL | |
| 2442 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | | Neg | | | | | Neg;$Cutoff = 200 ng/mL | |
| 2443 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | | | | | | |
| 2444 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | GFR | EGFR by MDRD | | 80 | | | | | mL/min/1.73m^2$No Ref Rng | |
| 2445 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | | 137 | | | | | 116 - 164 | g/L |
| 2446 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | | 0.46 | | | | | 0.34 - 0.48 | |
| 2447 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | | 4.3 | | | | | 4.1 - 5.6 | TI/L |
| 2448 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | | No Review Required | | | | | NORMOCYTIC;$NORMOCHROMIC | |
| 2449 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | | 106 | | H | | | 79 - 98 | fL |
| 2450 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | | 5.54 | | | | | 3.8 - 10.7 | GI/L |
| 2451 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | | 2.33 | | | | | 1.96 - 7.23 | GI/L |
| 2452 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | | 2.64 | | | | | 0.91 - 4.28 | GI/L |
| 2453 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | | 0.36 | | | | | 0.12 - 0.92 | GI/L |
| 2454 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | | 0.15 | | | | | 0 - 0.57 | GI/L |
| 2455 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | | 0.07 | | | | | 0 - 0.2 | GI/L |
| 2456 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | | 42.0 | | | | | 40.5 - 75 | % |
| 2457 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | | 47.6 | | | | | 15.4 - 48.5 | % |
| 2458 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | | 6.5 | | | | | 2.6 - 10.1 | % |
| 2459 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | | 2.7 | | | | | 0 - 6.8 | % |
| 2460 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | | 1.2 | | | | | 0 - 2 | % |
| 2461 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | | 301 | | | | | 140 - 400 | GI/L |
| 2462 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | | 5.3 | | | | | <6.5% | |
| 2463 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | | 4.36 | | | | | 1.9 - 23 | uIU/mL |
| 2464 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | | | | | | |
| 2465 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | | | | | | |
| 2466 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | LIPID PANEL | Direct HDL-C 4th Generation | | 1.94 | | H | | | 1.03 - 1.53 | mmol/L |
| 2467 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | LIPID PANEL | Triglycerides (GPO) | | 1.55 | | | | | 0.51 - 2.42 | mmol/L |
| 2468 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | LIPID PANEL | Cholesterol (High Performance) | | 6.28 | | | | | 4.01 - 6.85 | mmol/L |
| 2469 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | LIPID PANEL | LDL Chol Friedewald 4th | | 3.63 | | H | | | 0 - 3.34 | mmol/L |
| 2470 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | | No | | | | | | |
| 2471 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | RETICULOCYTES | Reticulocyte Count % | | 1.2 | | | | | 0.6 - 2.5 | % |
| 2472 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | SERUM BETA HCG | B-hCG, Qualitative | | Negative | | | | | Ref Rng: Negative | |
| 2473 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | SERUM BETA HCG | B-hCG, Quantitative | | <0.6 | | | | | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |
| 2474 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | TSH | TSH 3rd IS-QT | | 1.391 | | | | | 0.45 - 5.33 | mIU/L |
| 2475 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Specific Gravity | | 1.018 | | | | | 1 - 1.04 | |
| 2476 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur pH | | 6.0 | | | | | 5 - 8 | |
| 2477 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Protein | | Negative | | | | | Ref Rng:Negative | |
| 2478 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Glucose | | Normal | | | | | Ref Rng:Normal | |
| 2479 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Ketones | | Negative | | | | | Ref Rng:Negative | |
| 2480 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Bilirubin | | Negative | | | | | Ref Rng:Negative | |
| 2481 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Urobilinogen | | Normal | | | | | Ref Rng:Normal | |
| 2482 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Blood | | Negative | | | | | Ref Rng:$Negative-Trace | |
| 2483 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Nitrite | | Negative | | | | | Ref Rng:Negative | |
| 2484 | CZ100040002 | | | 46 | years | Female | Part 1 Screening | | Sep 19, 2025 9:20 AM | 6225350972 | URINE MACRO PANEL | Ur Leukocyte Esterase | | Negative | | | | | Ref Rng:Negative | |
| 2485 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | C-REACTIVE PROTEIN | C Reactive Protein HS | | 2.1 | | | | | 0 - 5 | mg/L |
| 2486 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Total Bilirubin | | 5 | | | | | 3 - 21 | umol/L |
| 2487 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | | 1.6 | | | | | 0 - 6.2 | umol/L |
| 2488 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Alkaline Phosphatase | | 104 | | | | | 35 - 104 | U/L |
| 2489 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | ALT (SGPT) | | 30 | | | | | 4 - 43 | U/L |
| 2490 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | AST (SGOT) | | 27 | | | | | 8 - 40 | U/L |
| 2491 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | GGT | | 20 | | | | | 4 - 49 | U/L |
| 2492 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | LDH | | 224 | | | | | 53 - 234 | U/L |
| 2493 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Urea Nitrogen | | 4.6 | | | | | 1.4 - 8.6 | mmol/L |
| 2494 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | | 75 | | | | | 31 - 101 | umol/L |
| 2495 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Glucose Fasting | | 5.2 | | | | | 3.9 - 5.6 | mmol/L |
| 2496 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Serum Uric Acid | | 358 | | | | | 149 - 446 | umol/L |
| 2497 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Calcium (EDTA) | | 2.38 | | | | | 2.07 - 2.64 | mmol/L |
| 2498 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Phosphorus | | 1.33 | | | | | 0.71 - 1.65 | mmol/L |
| 2499 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Total Protein | | 72 | | | | | 61 - 84 | g/L |
| 2500 | CZ100040001 | | | 56 | years | Female | Part 1 DB Baseline | | Sep 5, 2025 7:55 AM | 6225350981 | CHEMISTRY PANEL | Albumin-BCG | | 46 | | | | | 33 - 49 | g/L |
